| |
April 2007 - Volume 1, Issue
2
TOWARD MAKING PREGANCY
SAFER
 |
Dr. Thamer Kadum Yousif Al
Hilfy
MBChB/DCM/FICMS
JMHPE/MsC/Member/medical education
Director Health For All Center (NGO) / Iraq-Baghdad
Assistant Professor / Alkindy College of Medicine/Baghdad
|
 |
Tel. +96417721963
+9647703459903
Mobile. +9647901734108
E-mail: thamer_sindibaad@yahoo.com
thamer_center2005@yahoo.com
|
 |
|
ABSTRACT
Background:
This study was carried out in an attempt to demonstrate
the epidemiology of safe pregnancy outcome in Iraq.
Safe pregnancy is defined as the period encompassing
pregnancy, childbirth and the postpartum, which is experienced
without complications for both the mother and the fetus/baby.
Methodology: The current
work represents an observational longitudinal study,
which included (2080) cases of all pregnant women who
terminated their pregnancy by delivery, abortion or
ectopic pregnancy, or within (42) days after termination
of pregnancy, who attended gynecological, obstetrical
wards, outpatient clinic and the reproductive health
center (family planning clinic) in Tikrit Teaching hospital
for the period between the first of November to the
end of April (2006). A direct interview was done with
every woman; special questionnaire and a physical examination
was conducted only for women and their babies included
in our study, and investigations done when needed.
Results: It had been found that of the total
(2080) women, (1060, 51%) had a safe pregnancy outcome
for both mother and her fetus/newborn, and (1020, 49%)
had unsafe outcomes either for mother or her fetus/newborn.
The total sample was also classified into four groups
according to safety of mothers and babies, to make results
more accurate. These groups included safe pregnancy
outcome for both mother and her fetus/newborn, unsafe
outcome for both, safe mother outcome and unsafe fetus/newborn
outcome, and unsafe mothers with safe fetus/newborn
outcome. The total number of each group of previous
groups of mothers and fetuses/newborns, differed from
table to table, or figure to another according to their
relationship with other variables. The study also determined
the rate of perinatal, and maternal mortality, and its
causes.
The results showed that, there were many maternal related
factors affecting pregnancy outcome that included adolescent
mothers, uneducated (not able to read and write) women,
grandmultiparas, and women who had broken marital relations
(mostly separated) associated with unsafe pregnancy
outcome.
Rural residence had been associated with unsafe pregnancy
outcomes. The study found that, consanguineous marriage
(second degree relative) was associated with unsafe
pregnancy outcomes.
Fetal related factors had an effect on pregnancy safety.
Single fetus pregnancy, normal newborn birth weight
(2500-4000) gm was associated more with safe pregnancy
outcome.
Good antenatal care of mothers
was associated with safe pregnancy outcome, particularly
in those women who attended both private doctor's clinic
and primary health care center.
Women who received tetanus toxoid immunization completely,
and who spaced their pregnancies more than two years
apart, had safer pregnancy outcomes.
The women who completed (37-42)
weeks of gestation, with hospital delivery, beside intrapartum
regular fetal heart monitoring, and labor within normal
duration had been associated with safe pregnancy outcomes.
Rh incompatibility problems between mother and fetus/newborn,
bad obstetrical history, positive medical and gynecological
and obstetrical surgical problems of mothers had been
associated with maternal and fetal/newborn complications.
Conclusion and Recommendations:
We concluded from this study that, maternal complications
are more frequent in the ante partum period, while fetal
complications happened more in the post partum period.
Regarding the perinatal morbidity and mortality, predisposing
factors had been related mostly to maternal causes.
About maternal deaths, the
study found that most of deaths occurred in the first
42 postpartum days due to direct causes related to pregnancy.
The critical issue of maternal mortality encourages
us to compare our results with other corresponding studies
in the world, and then ratios and the major causes of
maternal mortality were determined.
We recommended improvement
of maternal health, and neonatal health. This could
be achieved by serious cooperation between community
(general population), health institutions and their
staff.
|
INTRODUCTION
Every year about (210) million become
pregnant in the world (1). Every minute of every day, somewhere
in the world and most often in a developing country, a woman
dies from complications related to pregnancy or childbirth.
That is (515,000) women, at the minimum, die every year. Nearly
all maternal deaths (99%) occur in the developing world (2).
For every woman who dies, 30 to 50
women suffer injury, infection, or disease. Pregnancy related
complications are among the leading causes of death and disability
for women aged 15-49 in developing countries. When a mother
dies, children lose their primary caregiver, communities are
denied her paid and unpaid labor, and countries forego her
contributions to economic and social development. A woman's
death is more than personal tragedy; it represents an enormous
cost to her nation, her community, and her family. Any social
and economic investment that has been made in her life is
lost. Her family loses her love, her nurturing, and her productivity
inside and outside the home (2).
In developing countries, women's
risk of dying, from pregnancy related disorders is on average
about 250 times greater than women in most developed countries(1).
In the world more than 70% of maternal
deaths are caused by just five conditions: bleeding after
delivery - 25% of deaths, infection after delivery - 15%,
unsafe abortion - 13%, hypertensive disorders - 12%, obstructed
labor - 8%. In addition, about 20% of maternal deaths are
due to diseases that are aggravated by pregnancy such as cardiovascular
diseases, chronic anemia, gynecological infections, pyelonephritis,
chronic renal diseases, malaria, fistulas, uterine prolapse,
chronic pelvic pain, and depression also affect large numbers
of women (1).
More than a decade of research has
shown that small and affordable measures can significantly
reduce the health risks that women face when they become pregnant.
Most maternal deaths could be prevented if women had access
to appropriate health care during pregnancy, childbirth, and
immediately afterwards (2).
In Iraq health statistics, the population
of Iraq during 2002 was estimated to be 5,565,000 with an
urban: rural ratio of 67:33 .The childbearing age women (6.064.000).
The health indicators for Iraq are as follows: Maternal mortality
ratio is 294/100,000 live births. The percentage of pregnancies
at risk is 37.8%. The total fertility rate for Iraqi women
is 6% and contraceptive use is 32%. The estimated lifetime
risk of maternal death of women in Iraq is 1 in 57. The literacy
rate for Iraqi women is 74%. The proportion of maternal deaths
taking place during the puerperium is 49%. The main causes
of maternal deaths are bleeding (46.4%), followed by acute
pulmonary embolism (11.9%), hypertension (8.3%), abortion
complications (5.7%), sudden death and irreversible shock
(2.3% each), sepsis and obstructed labor (1.1%) (3).
In Salah Al-Deen governorate about 292,000 women are at reproductive
age, and the maternal mortality ratio in the governorate is
about 29 per 100,000 live births. The most common causes of
maternal death were hypertensive disorders, hemorrhage, and
midwives' interference (4).
Many of the causes of maternal
deaths and disabilities also jeopardize the survival and health
of newborn infants (1). Every year in the world nearly 4 million
newborn babies die during the first month of life, an additional
4 million are stillborn (2), and millions more are disabled
because of inadequately managed pregnancies and deliveries,
and because of women's poor health and poor nutritional status.
Neonatal infection accounts for 33% of deaths in newborn babies;
asphyxia and trauma at birth account for 28%, premature delivery
and low birth weight account for 24%, and congenital anomalies
around 10% (1), while about 40%-80% of cases of newborn death
were due to low birth weight (2).
Newborn health and survival are
closely linked to the health of the mother before and during
pregnancy, as well as during labor, childbirth, and the postpartum
period. Key interventions or improving mother and newborn
health include ensuring that all women receive effective,
affordable, accessible, and acceptable maternity care (2).
In Iraq, health statistics record
that neonatal mortality rate is 67/1000 live births, and the
prevalence of low birth weight is 23.1% (3).
In Salah Al-Deen governorate the
prenatal mortality ratio was 257 per 100 000 live births(4).
In Tikrit General Teaching Hospital, the statistical records
were incorrect and not accurate because of insufficient records
supplied by the health office. Regarding 2005, recorded maternal
mortality number was only 3, while the perinatal mortality
is not recorded and neonatal death is recorded as infant mortality
(5).
AIM
The aim of this study is to contribute
to achieving of safe pregnancy outcomes among Iraqi childbearing
women.
OBJECTIVES
The study is conducted to:
- Identify effective practices that
could improve maternal and neonatal health.
- To recognize the extent and major
determinants of maternal mortality and morbidity.
- To assess the effect of abortion,
delivery site, duration of labor and maternal RH on mothers
safety.
-
To estimate fetal monitoring during pregnancy and labor.
- To describe causes of maternal
death.
SUBJECTS AND METHODS
Design
of the study:
The current work represents an observational longitudinal
study, which was conducted from 1st November 2005 to April
2006, and within regular working hours. The study design suited
the purpose of this research, and is feasible both from financial
as well as technical points of view.
Socio-Demographic characteristics:
The study was conducted in Tikrit General Teaching Hospital,
which represents one of the biggest centers located in the
center of Tikrit city, which serves a large proportion of
the community from different sectors of Salah Al Deen.
Salah Al-Deen Governorate has an
estimated population of 1,162,490 persons; Tikrit city represents
159,721 of the population. About 292,000 females or 20% of
Salah Al-Deen population, are females at reproduction age
(15-49 years old).
The study groups:
Sampling population: Our sample included all females who
attended Tikrit General Teaching Hospital for delivery (pre
term, term or post term), abortion, ectopic, or attending
for contraceptive advice, check up, or for treatment of any
complications, within 42 days of termination of pregnancy,
and who attended from the first of November 2005 to the end
of April 2006. This includes 2080 pregnant women. Those females
were followed in the gynecological and obstetrical wards,
outpatient clinic of gynecology and obstetrics, and family
planning clinic.
The total sample was classified into four groups which includes
the following:
Safe mother and fetus outcome (newborn),
unsafe outcome for both mother and fetus, safe mother outcome
with unsafe outcome regarding fetus/newborn and the last group
is safe fetal/newborn outcome with unsafe outcome regarding
the pregnant women. This classification was introduced for
the sake of more accurate results.
Our results were compared with three
major studies dealing with same concerns. A meta analytic
approach was used to study some common variables mainly the
maternal mortality ratio (women who died within 42 days postpartum
due to direct and indirect causes related to pregnancy).
The total sample size chosen is considered
to be suitable in this design study for showing the expected
degree of differences regarding different variables. It is
known that the sample size had an inverse relationship with
alpha error.
As regards the power of the study
it is acceptable to use 0.8(80%), as this will guarantee,
as we believe that B error will have a limited effect at this
level (accepting the null hypothesis when it is false) .
Pilot study and preset:
The real benefit of a pilot study in this research is its
usefulness as a pretest measure, done on small scale, to identify
any area of ambiguity or weakness related to the research
design and tools, besides the acceptability of the community
and subjects of the study sample to the research. A small
scale pilot study was carried out on a sample of 30 cases
and included women pregnant, delivered, and aborted. This
pilot study was run for 3 weeks before the study was launched.
The consent of those participating in the study was also tested
to ensure the clarity of the language and to give an indirect
idea about the acceptability of the sampling population.
We did look for any possibility of
error and tried to correct it from the beginning as part of
quality control measures. Thus quality checks will be set
at each state of data collection.
Another seminar was made in the Community Medicine Department
in Tikrit College of Medicine, in the presence of the chairman
of the department and postgraduate students of the college.
Discussion was made, and comments, notes and suggestions were
given by the audience, which were very worthy, and helped
much in conducting the final study in a more perfect and practical
way.
Development of Questionnaire and
Data Collection:
The questionnaire was developed to collect all the data relevant
to socio-economic class, and all variables listed below using
structured interviewing and simple questionnaire. The interviewing
here has the advantages of both the questionnaire and the
observation. The response of the study sample was high and
was suitable even for illiterates. The possibility of a skewing
effect is not high since the required data are not critical
to the interviewee, and ethical issues relating to the questions
were considered. All questions were to be part of the interview.
Issues of confidentiality were foremost and checking on data
entry is done on a regular basis.
Age:
It included five age groups (<16, 16-25, 26-35, 36-45,
>45) years old.
Occupation.
Marital status.
Residency.
Rh of both parents and baby, which is very important when
the mother is Rh negative and the father is Rh positive.
Degree of consanguinity between parents.
Points related to ANC at antenatal
period of women include:
Parity: (Zero), (1-4), (=5) babies delivered after 24th weeks
of gestation.
Gravida.
Abortion.
Last menstrual period to determine gestational age, and expected
delivery date.
ANC was performed with adequate visits or not, and where (private,
PHCC, or both).
Immunization: Tetanus toxoid if received by pregnant women
completed, or not.
Risky mothers determined with level of risk and its causes.
Any complication during this period.
Termination of pregnancy, abortion and its type, ectopic pregnancy,
or stillbirth at which gestational age, causes, and complications.
Intra-partum period
Labor: Full term, preterm, post term.
Site of delivery: Hospital, home.
Duration of labor.
Type of fetal monitoring in the intrapartum period.
Type of delivery: Spontaneous vaginal delivery, normal vaginal
delivery with induction, C/S, or instrumental.
Complication during this period (mother, baby).
Number of babies, gender and weight of baby.
Postpartum complications (early, late).
Subjects and Methods
Past obstetrical history:
Number of previous pregnancies.
Outcome of previous pregnancies.
Type of delivery.
Effect of ANC and PNC.
Spacing: It calculated average birth spacing among all pregnancies.
Birth spacing less than 2 years, or more than 2 years.
Contraception use and type .
Drug history for:
Preconception preventive drugs.
Specific diseases.
Regarding pregnancy.
Medical history: Cardiovascular diseases, diabetes mellitus,
blood diseases, renal diseases and others.
Surgical history: Pelvic (gynecological, obstetrical, or non
gynecological), and others.
Social history: Smoking, alcohol, illicit drugs.
Family history: Chronic diseases, multiple pregnancy, hereditary
diseases, congenital anomalies.
Examination:
Clinical assessment for every woman who was at ante-partum,
intra-partum, and post-partum period, and her neonates.
Blood pressure.
Abdominal examination (fundal level at ante-partum, and post-partum
periods).
Mother weight and height.
Fetal heart rate monitoring.
Weight of baby.
APGAR score of baby at first 5 minutes.
Per vaginal examination.
Statistical analysis:
Our study is a cross sectional study, and we will describe
the characteristics of the sample choosing the methods of
analysis depending on the type of data, whether qualitative
or quantitative.
Most of our results are of a qualitative
nature and so using chi square to test any significance, will
be of benefit.
Several descriptions to explore our
analysis were used and were not restricted to table presentation,
whether percentages or frequency distribution but also including
graphic presentation as a `Bar chart' as we are dealing here
with qualitative data.
The data collected on 2080 women
were included in the study to assess the association of many
risk factors with safe outcome (for the mother and the baby).
So conventional statistical techniques
were applied to the data in the study of distribution by frequency
percentage, tables, and graph presentations. Considering the
level of significance for this study is 0.05 for the sake
of minimizing alpha error (rejecting the null hypothesis when
it is true).
Statistical analysis was done using
the new version of Minitab package/2006.
RESULTS
The total sample studied in this
research was 2080 women who were pregnant then terminated
their pregnancy, or within 42 days of termination, and attended
the hospital. In general regarding the outcome including the
mothers and babies 1060, (51%) were classified as safe pregnancy
outcome, and 1020, (49%) as unsafe pregnancy outcome. The
number of safe mothers was 1257, and unsafe mothers 823, but
after exclusion of abortion and ectopic pregnancy the number
of safe mothers became 1180 and unsafe mothers 780. The number
of safe babies was 1680, and unsafe babies 400, but after
exclusion of abortion (118) and ectopic pregnancy (2) the
remaining unsafe babies were 280. Both mothers and babies
were safe (1060), both unsafe (160), safe mothers and unsafe
babies (120), unsafe mothers and safe babies (620), the number
of twins (80) babies, except for abortion and ectopic pregnancy.
Regarding the maternal age the study showed that, those who
had safe pregnancy outcome were aged 16-25 years, and their
number was 518 (56.4%), and those who had unsafe pregnancy
outcomes where at the age <16 and their number 40 (95.2
%). Table (1)The study demonstrated the association between
maternal educational level and outcome in that 728 (76%) of
safe pregnancy outcomes were of literate women, while regarding
the unsafe pregnancy outcome 790 (70.4%) were illiterate women.
Table (1)
Regarding the relationship between
parity and pregnancy outcomes, the study showed that, 523
(56.4%) of safe pregnancies were in (1-4) of the parity group.
While 166 (62.9%) of unsafe pregnancy outcomes were in (=5)
parity group. Table (1) The
study showed that 1054 (54.1%) of safe outcomes were in married
women, but most of the unsafe outcomes were in separated women
and their number was 76 (96.2%). Table (1)
Regarding the fetal and maternal safety in relation to number
of fetuses, total fetuses were 2040 after exclusion of abortion
and ectopic, and inclusion of twins. Among single fetuses
pregnancy, 1068 (54.5%) had a safe outcome. But among multiple
fetuses pregnancy, 13 (16.2%) had safe pregnancy outcomes.
Table (2)
Regarding the gender, the total
(2040) and the study showed that, equal effect of both male
and female gender on safety of pregnancy outcome, 540 (53%)
of males and 541 (53%) of females had a safe pregnancy outcome.
Table (2)
Regarding weight of babies, the study demonstrated 3 (100%)
of babies with extreme low birth weight [<1000] gm had
unsafe pregnancy outcomes. While 74 (100%) of babies with
very low birth weight [<1500] gm had unsafe pregnancy outcomes.
134 (100%) with low birth weight [<2500] gm, also had unsafe
pregnancy outcomes. But 1080 (61.3%) of normal birth weight
[2500-4000] gm had safe pregnancy outcomes, while 1 (1.5%)
of macrosomic babies with weight [>4000] had safe pregnancy
outcomes.
Regarding residency distribution,
the study showed that, 674 (65.7%) of safe outcomes were living
in urban areas, while 386 (36.6%) of safe outcomes lived in
rural areas. Figure (1)
Regarding the degree of parental
consanguinity, the study showed that, 104 (8.5%) of non-related
couples had unsafe pregnancy outcomes, while 126 (45.7%) in
second degree relative couples had unsafe pregnancy outcomes.
Figure (2)
The study showed that, 939 (68.9%) of safe pregnancy outcomes
had good antenatal care (=5visits), while 13 (12.6%) of safe
outcomes had no antenatal care at all. Table
(3)
After
referring to ANC visit and its type, the study demonstrated
the relation between antenatal care site and pregnancy outcome.
After exclusion of women with no ANC, the total was 1977,
314 (66.8%) of safe outcomes attended both private, and primary
health care centers, while the lowest, 185 (33.3%) of safe
outcomes were in those who attended the primary health care
center only. Table (4)
The study showed that most (422 - 86.5%) of mothers who completed
immunization had safe mother and baby outcomes, while 138
(18.6%) of mothers who did not receive immunization had safe
pregnancy outcomes. Table (5)
Regarding the relationship between birth spacing and safe
pregnancy outcomes, of the total number of women (2080), the
total of both unsafe mother and baby outcomes was (160)+(41)
of unsafe mothers from abortion +(2) ectopic pregnancies (total)
=203], when safe mother and unsafe baby the total was [120
+ (77 safe mothers from abortion) =197]. The study showed
that, spacing period (>2) years 720 (64.6%) had both mothers
and babies safe, while 68 (6.1%) had unsafe mother and fetus.
And regarding the spacing period (<2) years 368 (38.1%)
had unsafe mothers and safe babies, while only 123 (12.7%)
had safe mothers and unsafe babies. Table (6)
Regarding the risky women the study showed that the total
risky mothers were (1400), while 125 (89.3%) of severe risk
level had unsafe pregnancy outcomes, and 310 (43.4%) of high
risk level had safe pregnancy outcomes.
The study showed that in 118 cases of abortion, there was
a comparison between the type of abortion and mother health.
Most 24 (92.3 %) of threatened abortion had safe mother outcomes,
while the lowest, 1 (10%) of septic abortions had safe mother
outcomes. But most 9 (90%) of septic abortion had unsafe mother
outcomes, while lowest zero (0%) of inevitable abortions had
unsafe mother outcomes. Table (7)
Among the total delivered mothers
(1960), the study showed that, 969 (56.2%) of full term pregnancies
had safe mother and fetus/baby, while 35 (40.7%) of preterm
deliveries had safe mothers and unsafe fetuses/babies outcome.
And 80 (53%) of post term delivery had safe pregnancy outcomes
for both. Figure (3)
The study showed that from a total
1960 delivered women, after exclusion of abortion and ectopic
pregnancy cases, 1017 (55.8%) of hospital delivery, had safe
pregnancy outcomes regarding both mothers and fetus/baby,
while 43 (62.3%) of those who had home delivery by a registered
midwife, had safe outcomes for both, while 5 (100%) of home
deliveries when not aided at all, were both mothers and babies
having unsafe outcomes. Table (8)
Regarding the relationship between
mode of delivery and pregnancy outcome, the total was 2040
after inclusion of twins and the study showed that, 461 (53.5%)
of thosedelivered by spontaneous vaginal delivery had complications.
Also 289 (61.8%) of induced vaginal delivery had complications,
while in cesarean section, from 179 mergency cesarians 145
(81%) hadcomplicated delivery, but from 330 of elective C/S
30 (9.1%) were complicated. Table (9)
After exclusion of 330 elective cesareans,
and 45 of emergency C/S, total women who had true labor were
(1585). The study showed that, those who had normal duration
of labour with safe outcomes were higher in primigravida 377
(79.9%), in comparison with multigravida 433 (73%). But in
safe pregnancy outcomes with prolonged labor 91 (39.6%) were
primigravida, while 40 (13.8%) were multigravida.
Table (10)
The total
number of women who received intra-partum fetal monitoring
was 1360 after exclusion of home delivery (138), and (462)
without monitoring, the study showed that, 844 (79.1%) with
regular fetal heart monitoring had safe babies, while only
223 (20.9%) had complications. Furthermore, partogram was
used in 273 (93.2%) with safe fetal outcomes but only 20 (6.8%)
were associated with complications. Table (11)
Regarding the problem of Rh incompatibility of mother and
after exclusion of abortion and ectopic pregnancy cases, the
total was 1960. Then the study showed that, most 1480 (89.2%)
of Rh positive mothers and babies hadsafe pregnancy outcomes,
while the highest 83 (51.6%) of Rh negative mothers and Rh
positive babies had unsafe pregnancy outcomes. Table
(12)
Regarding the effect of medical,
and surgical history of mother, and family history of both
parents on outcomes: In regard to medical illnesses, 51 (38.6%)
of acute illnesses were associated with unsafe mother and
fetus/baby outcomes, while 165 (42%) of chronic illnesses
were associated with unsafe mother and fetus/babies.
Regardingsurgical history: the highest
incidence 240 (59.6%) of gynecological and obstetrical operations
was found in unsafe mothers and safe fetus/baby, while the
highest incidence 86 (52.1%) of non gynecological operations
was found in both safe outcomes for mother, and fetus/baby.
Regarding family history: the highest
incidence 43 (58.9%) of family history of inherited disorders
was found in safe mother and unsafe Fetus/baby outcomes, while
the highest incidence 190 (78.2%) of family history of multiple
pregnancies was found in both safe mother and fetus/baby,
and the highest incidence 648 (59%) of family history of medical
diseases was found in both safe mother and fetus/baby. Table
(15)
Regarding the drug history, the study
showed that, women using preconception preventive drugs with
harmless effects 60 (84.5%) had both safe outcomes, while
7 (100%) of women using harmful drugs had safe mothers and
unsafe babies outcomes. Regarding ante partum drugs, tonics
948 (64.9%) had both safe pregnancy outcomes; while regarding
the drugs used for specific diseases for women 305 (59%) both
had safe outcomes. Finally regarding intrapartum drugs which
include antihypertensive drugs 43 (26.4%) had both unsafe
outcomes, while using anti-convulsant drugs the study showed
that 17 (56.7%) had unsafe outcomes for both, and oxytocic
drugs 182 (70.3%) both showed safe outcomes. Table
(16)
Furthermore the study showed the
effect of risk factors on maternal and fetal/baby health.
We determined the top10 factors that affect feto-maternal
safety in order from highest to lowest. The study showed that
1099 (22.2%) of risk factors had family history of medical
diseases, then 426 (8.6%) hadprevious C/S, then 345 (7%) had
toxemia or hypertension in previous pregnancies, then anemia
(<10 g/l) 338 (6.8%), then 318 (6.4%) were hypertensive
women in the present pregnancy. Then 300 (6.1%) child weight
(<5Ib, >9Ib), followed by risk of history of (=2) abortion
or history of infertility or postpartum hemorrhage 292 (5.9%),
then bleeding (>20, <20) weeks of present gestation
288 (5.8%), then 264 (5.3%) due to parity (>5), and lastly
I.U.G.R. 168 (3.4%). Table (16)
Regarding the causes of perinatal
mortality the study shows that of 120 perinatal mortalities,
the highest 72 (60%) were due to maternal causes, while the
lowest 12 (10%) were due to fetal causes (multiple pregnancy).
The study showed that total maternal
deaths was 11 women. Of thesethe highest number was due to
direct causes in the first (42) days which was 5 (45.4%) women.
The lowest number was 1 (9.1%) due to direct and indirect
causes in the period between (42) days to first year postpartum
for each. Table (13)
The study showed that the total
number of mothers who complained of complications was 1150.
The highest incidence of maternal complications 369 (32.1%)
were in the ante-partum (third trimester) period, while the
lowest 3 (0.3%) were in the post-partum (after 42 days-1 year).
The total number of fetuses who had complications was 446.
The highest incidence of fetal complications 150 (33.6%) were
in the intra-partum period, while the lowest, zero (0%) were
in the post-partum (after 42 days of termination).
Table (14)
The study determined the major causes
of maternal mortality which were 2 (28.6%) for each of hypertensive
disorders, and hemorrhagic problems of pregnancy. Maternal
mortality ratio was 161 per 100,000 live births in Tikrit
General Teaching Hospital. Table (17)
DISCUSSION
Making pregnancy safer for both
mothers and fetuses/babies is important because for every
woman who dies, 30 to 50 women suffer injury, infection, or
disease. Pregnancy related complications are among the leading
causes of death, and disability for women age 15-49 in developing
countries. In addition, newborn health and survival are closely
linked to the health of the mother before pregnancy, during
pregnancy, during labor, and in the postpartum period (125).
The study showed that the predominant
childbearing age group was from 16-25 years, while Mahoney
R. observed that the predominant childbearing age group was
from 25-34 years (126). Also our study showed that age <16,
>45 years was associated with unsafe pregnancy outcomes.
This agrees with Wasunna A., and Mohammed K. who observed
that adolescent mothers were more likely to have increased
morbidity, and adverse outcomes particularly low birth weight
problems of newborns <2500 grams (127), but this rejected
by Kirchengast S., and Hartman B. who observed that adolescent
mothers showed no increased incidence of low birth weight
problems (128).
Also Kirchengast S., and Hartman
B. and Donoso E., and Villarroe L. observed that the women
older than 40 years had a higher rate of cesarean section,
maternal death, late fetal death, and neonatal death. This
is interpreted as an increase in the mother's age is associated
with an increase in mother and newborn body dimensions(128,129).
Regarding the maternal educational
level, the results showed an association between uneducated
mothers (illiterate) and unsafe pregnancy outcomes. This agreed
with Wasunna A., and Mohammed K. in Nairobi, the study observed
women who had less formal education, and who were unemployed
had obstetrical risks for poor pregnancy outcomes (127).
The results showed an association
between the parity group of =5 and unsafe pregnancy outcome.
This was in agreement with Olatunji A.O., and Sule-odue A.O.
in Nigeria, and Williams K.P. and Wilson S. that the primiparous
and the grandmultiparous women had a high risk of poor pregnancy
outcome particularly small for gestational age, HELLP syndrome,
operative delivery, and maternal death (130,131).
Marital state showed an association
between broken marital states, especially separated women
and poor pregnancy outcomes.
Conditions in Iraq, and in Tikrit
city particularly, mean that pregnant women suffer from stressful
events, either psychological, economical, or social effects.
Additionallythere are large numbers of their husbands in American
Prisons that affect negatively on pregnancy outcomes. This
agrees with data from Perren S., Von-Wyl A., et al, (US Conferences
of Mayors), and (National Coalition for the Homelessness -NCH-).
Homeless women who are pregnant usually with inadequate prenatal
care, limited access to general health care, poor nutrition
and inadequate housing leads to poor birth outcomes (132,133.134).
The complications of homelessness include an increased incidence
of low birth weight newborn, and a higher rate of infant mortality,
in addition to risk of many illnesses that could negatively
affect their pregnancies, or substance abuse (134).
Considering the number of fetuses,
and intra-partum and post-partum complications, the results
found that the mother and fetal/baby complications associated
with multiple gestation, but safe pregnancy outcome associated
with singleton pregnancy. This agrees with Senat M.V., et
al who also determined the most common complications associated
with multiple pregnancy which includes maternal anemia due
to increased demand of multiple gestation, hypertension, polyhydramnios
or may be due to increased renal perfusion, premature rupture
of membranes, incompetent cervix, intrauterine growth restriction,
and other rare complications as conjoined (Siamese) twins,
and other labor complications which include preterm labor,
uterine dysfunction, abnormal fetal presentation, instrumental
or cesarean birth and post-partum hemorrhage (135) . But Jacquelyn
Y., Martens G., et al found that the perinatal mortality was
significantly lower in twins because of early fetal death,
and not early neonatal mortality (136). Francois K., Johnson
J.M., and Harries C. observed that the occurrence and complications
of placenta previa do not differ between singleton and multiple
pregnancy (137).
Regarding gender of babies the results
showed no differences between both males and females with
safety of pregnancy outcome. Neville F., Moore G. astated
that newborn gender may provide insight into patient and family
expectation and may indicate certain genetic risk factors,
also fetal and neonatal complications (11).
The results found that all babies
who had extreme low birth weight (<1000) grams, and very
low birth weight (<1500) grams usually were unsafe babies,
but in very low birth weight babies <2500 grams, the highest
number had unsafe fetus/baby outcomes., This agrees with Lynch
A., McDuffie R., et al (138). The results show that normal
weight of babies 2500-4000 grams) had safe fetus/baby and
mother, and the predominant weight (86.3%) was normal birth
weight (2500-4000 grams). This agrees with Misic Z., Krezo
S., et al who observed that the predominant newborn weight
(93.5%) was 2500-3000 grams (139). Macrosomic babies (>4000)
grams had unsafe fetus/newborn and mother outcomes. This agrees
with Boulet S.L., Alexander G.R., et al (140).
Considering area of residence, whether
rural or urban, there was an association between rural areas
and unsafe pregnancy outcomes, and urban areas with safe pregnancy
outcomes. These results interpreted as, that the rural area
has limited health services. In addition there are recent
circumstances of night curfews, and sometimes even during
the day, as well as insufficient fuel and high prices may
prevent pregnant women from reaching the central hospital
in Tikrit city. This made pregnant women experience traditional
birthing practices such as home delivery by unregistered midwives,
or unaided delivery, due to delay in arrival to hospital.
This result agreed with Kyomuhendo G.B. in Uganda, and Safdar
S., Ahmed S.T. in Pakistan who observed tharpoor pregnancy
outcome was more common in rural areas (141,142).
The results also showed that there
is an association between the parental consanguinity and fetal/baby
outcomes in that unrelated parents had safe fetal/baby outcomes,
but second degree relative parents had unsafe fetus/baby outcomes
according to our study results. This agrees with Sogaard M.,
Vedsted-Jakobsen A. who found that consanguineous couples
have a higher risk of having children with congenital malformations
(143). But our results disagree with Saad F.A., Jauniaux E.
in Qatar, and Al-Bustan S.A., El-Zawahri M.M., Ghunaim I.
et al who didn't find any relationship between consanguineous
marriage and poor fetal outcome (144,145).
Our study shows a positive relationship
between prolonged spacing of >2 years as average spacing
between pregnancies and good fetal/baby and maternal health,
but too close pregnancies are associated with poor pregnancy
outcomes. These findings agreed with the result found by (Anonymous)
that the couples who space their birth (3-5) years apart increase
their children's chance of survival, and mothers are more
likely to survive (146).
Also our study agreed with King J.C.
who found that women with early or closely spaced pregnancies
have increased risk of fetal-maternal morbidity and mortality
due to maternal nutrient depletion (125). Other studies done
by Rachel A., and Royce, and Agudelo A.C., et al showed that
close pregnancies, less than 18 months, had poor pregnancy
outcomes. This result was due to maternal nutritional depletion,
while the same study showed no statistically significant differences
in risk between women with pregnancy interval 18-24 months,
and those with intervals of 24-59 months. Regarding intervals
longer than 59 months, it is observed that there are more
maternal and fetal/baby problems, due tothat the woman's physiologic
reproductive capacity decline and thus becoming similar to
those of primigravida women. (19,147)
Considering abortion, the results
showed that the abortion rate was 5.7% from the total sample
(2080). Safe mother outcomes in cases of abortion were more
than unsafe mothers. These results were due to increased maternal
health education about the consequent complications of unsafe
abortion, and availability of medical services such as medical
staff, specialist doctors in obstetrics, trained sub staff,
and ultrasonography. Finer L.B., Henshaw S.K. found abortion
rate in (2000), in United State was (5%) (148). Our study
did not determine the causes of abortion accurately, even
maternal or fetal factors, because that needs some investigations
which are not available in our hospital or even in Salah Al-
Deen governorate, or it may be expensive and need a long time,
but the results determined the risk factors of unsafe pregnancy
outcome and abortion is part of it. There are different studies
about risk factors of abortion, Talukder S.I., and Haque A.
and Qublan H.S., Jumaian N., et al observed variation in the
frequency of abortion found to be highest in the hot seasons,
rural areas, old age women, and high parity (149,150).
Diejomaoh M.F., Al-Azemi M., et al in Kuwait determined the
main etiological factors of recurrent pregnancy loss were
uterine anomaly, chromosome anomaly, polycystic ovarian syndrome,
infections, and other miscellaneous factors. Positive phospholipids
antibodies are a most frequently associated cause of recurrent
pregnancy loss in Kuwait (151).
Considering antenatal care 65.5%
of the sample had good antenatal care, and 29.5% had poor
antenatal care, and 5% had no care at all. There was an association
between good antenatal care and safe mother and fetus/baby
outcomes because frequent visits and checking can determine
the risky groups, and follow up during pregnancy can determine
the appropriate mode of delivery; while there are increased
complications in women who had poor antenatal care. This is
documented by Chang J., Elam-Evans L.D., et al in the United
States, and Olatunji A.O., and Sule-Odu A.O. in Nigeria who
observed that unbooked patients were associated with poor
pregnancy outcomes and even pregnancy related death (152,130).
Regarding the antenatal care site,
whether private clinics or primary health care centers or
both, our study showed that the women who attended both private
doctor's clinics and primary health care centers were associated
with better pregnancy outcomes. This disagrees with Harvey
S., Rach D., et al in Canada who observed the significantly
higher satisfaction of the women with care provided by the
midwives together with better clinical outcomes, than doctors'
care (153).
Immunization with tetanus toxoid for pregnant women: There
is a known schedule used in Iraq which includes four doses.
The first dose is given in the first 6 weeks of pregnancy
which gives no protection, the second dose is given 4-6 weeks
later which gives protection for 3 years. The third dose is
given 6 months later which gives protection for the next 5
years, and the fourth dose is given one year later which gives
protection through the reproductive life. The result showed
that, there were positive associations between those women
who completed their tetanus toxoid immunization and good pregnancy
outcomes. This result, is documented by Nasheit N.A. in Iraq,
- that the tetanus toxoid played a role in decreasing perinatal
mortality in Iraq (154).
Considering risk factors of mothers
which determined the level of risk according to special risk
scoring system, the previous results demonstrated in the discussion
covered most of the risk factors and their effects, inregards
to the maternal weight affecting pregnancy outcomes, most
of the women with extreme weight had complications according
to our results, that agree with Neggers Y., and Goldenberg
R.L. and Edmonds D.K. (155, 28). Regarding maternal height,
most of the women shorter than 150 cm were associated with
mother and fetal/baby complications, but it may be due to
the contribution of other risk factors. Edmonds D.K. observed
that except in extreme cases (such as kyphoscoliosis or rickets)
short stature has only a weak association with pelvic contraction,
and is not usually an indication for extra care (28).
Regarding the duration of pregnancy,
the baby delivered either preterm (before 37 completed weeks
of gestation), or term at period 37-42 completed weeks of
gestation, or post term (after 42) completed weeks of gestation)
in our study, showed that there are variations in the mother
and fetus/baby complications that depend on the cause of preterm,
and post term delivery, type of management of labor, and neonatal
care facilities which are insufficient in Tikrit Teaching
General Hospital. All of these factors decided the fate of
pregnancy. The study showed that full term, and post term
delivery associated with better outcome than preterm delivery.
Regarding preterm delivery, our results
agree with Garland S.M., Ni-Chuileannain F. et al who observed
that premature or preterm delivery increased fetal susceptibility
to cerebral palsy and neonatal sepsis that increases mortality,
particularly extreme prematurity (156).
Ananth C.V., Smulian J.C., and Vintzileos
A.M. in United States showed that the effect of placenta previa
and neonatal mortality rate is according to duration of pregnancy.
The risk of death from placenta previa was lower among preterm
babies and higher in women without placenta previa, while
mortality rates for term births were higher among babies born
to women with placenta previa than among babies born to women
without placenta previa (157).
Regarding the post term delivery
Treger M., Hallak M., et al had a study that showed that the
main problems associated with post term pregnancy are stage
I, II, meconium stained amniotic fluid, macrosomia, and cesarean
section were significantly higher with increasing gestational
age and to decrease these problem, labor induction should
be indicated at appropriate gestational age (158). This was
opposite to our study results.
Regarding the duration of labor,
maximum duration in multipara is 14 hours, and in primipara
is 20 hours from commencement of true labor (10). The results
showed that prolonged labor is associated with increased labor
omplications for both primiparous and multiparous women and
their babies. This result agrees with Maghoma J., and Buchmann
E.J. (159).
The results showed that the hospital
delivery rate is more than the home delivery rate. This may
be due to the type of study which was a hospital based study,
and women who have home delivery usually to not attend the
hospital, unlesssevere complicationsoccur. In addition, recent
conditions that include difficulty in transport from home
to hospital due to fuel deficiency and night curfews, that
make women prefer to attend the nearest PHCC or private doctor's
clinic, and home delivery than coming to hospital. This agrees
with Kaufman J., and Jing F. in China who observed that hospital
delivery had more safe pregnancy outcomes (160).But Janssen
P.A., et al in British Columbia disagreed with our result
when they observed that planned home birth was not associated
with an increase in mothers' and fetuses/babies' complications.
They interpreted their results as due to labor managed by
well trained midwives (161).Conversely our results showed
that where labor was managed by registered midwives, it ewith
better outcomes than non registered midwives. This disagrees
with the result of Goldman N., and Glei D.A. in Guatemala
who observed similar results between trained and untrained
midwives (162).
Considering mode of delivery and feto-maternal complications
at intra-partum and post-partum periods, the results showed
that labor induction was associated with mothers, and fetuses/babies
complications more than complications from spontaneous vaginal
delivery. This disagrees with Shanchez-Ramos L., and Hsieh
E. who observed that labor induction provided the surveillance
for maternal and fetal safety (163).
Regarding instrument delivery, the
results showed that forceps delivery had safe outcomes higher
than unsafe outcomes, but vacuum delivery was not in use due
to instrumental defect. Ben-Aissia N., Gara M.., et al observed
that the major indication of forceps use was fetal suffering,
and the maternal and fetal prognosis depended on accurate
indication of the use of forceps (164). Shihadeh A. and Al-Najdawi
W. observed that maternal birth canal and genital tract lacerations
were significantly more common in forceps delivery and there
was significantly increased morbidity in infants delivered
by vacuum extraction (caput, jaundice, cephal hematoma), and
serious neonatal morbidity was rare for both groups (165).
Considering cesarean section, the results showed that emergency
cesarean section was associated with higher rate of mothers
and fetuses/babies complications than elective. This result
agreed with Bergholt T., Stenderup J.K., et al in Denmark
(166).
The objective of intra-partum fetal
heart monitoring is to prevent fetal asphyxia, and fetal death
during labor. The results showed that regular fetal heart
monitoring ended with good fetal/baby outcome because the
clinician can manage labor according to fetal monitoring results
This agreed with Freeman R.K., Williams K.P., and Galerneau
F., and Carbonne B., Gougeal V., and Fekih K.M. (167,168,169).
The use of partogram was limited
in Tikrit Teaching General Hospital because of insufficient
or unavailable papers of partogram that need economicsolutions.
Our results showed that the use of partogram in labor ended
with safe mothers and fetuses/babies, this agreed with Pattinson
R.C., Howarth G.R., et al who found that the partogram played
an important role in labor outcomes (170).
Regarding the Rh of mothers and babies,
a large number (84.7%) of mothers were Rh positive. These
results compared with Weiner C.P. who found that approximately
85% of white Americans, 92%-93% of African Americans, and
99% of the Asian population are Rh positive (171). The mother
with Rh negative, and baby Rh positive had unsafe fetal/baby
outcomes, either due to the problem of incompatibility or
other problems, Rh incompatibility happened when the mother
was previously sensitized, but iso-immunization can be prevented
if the mother receives Anti-D in the first (72) hours post
termination of each pregnancy according to our results. (American
College of Obstetricians and Gynecology) observed the highest
risk of Rh incompatibility if mothers were previously sensitized
(172).
The results showed a high rate of
maternal complications in the antenatal period, particularly
at third trimester. This agrees with Chakraorty N., Islam
M.A., et al in Bangladesh who observed a high rate of complications
in the antenatal period (173).This large number of complications
interpreted that, the women recall the problems because of
the seriousness of these problems, or the same women had multiple
problems in the antenatal period. These problems include ante-partum
hemorrhage, premature rupture of membrane, or leakingfluid,
threatened preterm labor and its causes, gestational hypertension
and other problems.
The results showed the highest rate
of fetus/baby complications occurred in the post-partum period.
This disagrees with Buchmann E.J., and Pattenson R.S. who
observed the highest frequency of fetal complications in the
intra-partum period, especially birth asphyxia (174).
Regarding maternal use of drugs taken in preconception, ante-partum,
and intra-partum periods, and fetomaternal.
Outcomes: The results showed that
the preconceptional drugs with harmless effects were associated
with safe pregnancy outcomes, such as using of folic acid
in the prevention of birth defects and neural tube defects.
This agrees with French M.R., Barr S.I., and Levy Milne R.
and Barash J.H., and Weinstein L.C. (175,176).
Regarding ante-partum drugs, the
results showed that tonics used during pregnancy were associated
with safe mother and fetus/baby outcomes. \-his result agrees
with Correa A., Botto L., et al (177).
Other drugs used in the ante-partum
period to treat specific diseases such as anti- hypertensive
drugs, depends on the type of drugs used and theirside effects.
This agreed with Duley L., and Henderson-Smart D.J. (178).
Other drugs used in the ante-partum
period were corticosteroids to decrease respiratory distress
syndrome. It is given in three doses as 12 mg for three consecutive
days to induce fetal lung maturation in threatened preterm
labor to decrease perinatal morbidity and mortality. The results
showed the positive role of corticosteroid, but Cran J., Armson
A., et al observed that a single course of corticosteroids
reduces perinatal mortality, respiratory distress syndrome,
and intra-ventricular hemorrhage, while repeated courses of
corticosteroids decrease respiratory distress syndrome, but
increase rates of neonatal and maternal
infection, fetal, neonatal, and maternal adrenal suppression,
decreased fetal or neonatal somatic and brain growth and increased
perinatal mortality (179).
Regarding drugs used in the intra-partum
period, the results showed that the hypertensive women who
needed intra-partum antihypertensive drugs had high blood
pressure during labor, and this hypertension did not respond
to usual ante-partum antihypertensive drugs, or women had
no antenatal care of diagnosed hypertension; therefore doctors
try other drugs to save mothers and fetuses/babies life if
possible, and according to our results both maternal and fetal/baby
outcomes are affected negatively in this group of pregnant
women.
Also the results showed that the
women exposed to oxytocic drugs in the intra-partum period
are associated with safe pregnancy outcomes. This result agrees
with Pattinson R.C., Howarth G.R., et al (170).
Regardinganticonvulsant drugs: (Valium,
Phenobarbital, and sometimes general anesthesia) used during
labor, and they were given when convulsion occurs due to hypertensive
disorders that are associated with unsafe mothers and fetuses/
babies. But Alberta by Foong S.C., and Pollard J.K. observed
that use of seizure prophylaxis for all women with gestational
hypertension from time of diagnosis through to (24) hours
postpartum, may have been able to prevent as many as 53% of
eclamptic episodes (180).
Many factors such as maternal history
of medical diseases (acute and chronic infectious diseases,
hypertension, diabetes mellitus, anemia, cardiovascular diseases,
renal diseases, epilepsy, psychological illnesses, and others),
maternal gynecological and obstetrical surgery (ovarian, tubal
surgery, uterine fibroid, cesarean section, cervical, and
others), and family history of inherited disorders (bleeding
disorders, chromosomal abnormality, congenital anomalies,
and others) all affect negatively on pregnancy outcomes. Most
common medical diseases of mothers that affect fate of pregnancy
wereanemia, particularly severe anemia were associated with
increased mother and newborn morbidity. This agrees with Malhorta
M., Sharma J.B., et al in a tropical African setting (181).
The other common disease was eclampsia which was a major cause
of maternal and fetus/baby morbidity and mortality. This agrees
with Beye M.D., Diaouf E., et al (182). Other disease was
diabetes mellitus and epilepsy, which are closely linked to
an increased risk of fetal malformation, and this agree with
Steel et al (183).
The high rate of perinatal mortality in our study is mainly
related to maternal causes. This agreed with Aisien A.O.,
Lawson J.O., et al in Nigeria (184). The perinatal mortality
rate related to fetal causes, agrees with Kinzler W.L., Ananth
C.V., et al who found that small size ofgestational age, if
exposed to labor stress, increases the risk of early neonatal
death (185). According to our results obstetrical complications
had the least effect on perinatal mortality. This was interpreted
that most fetuses at risk of labor complications were planned
for appropriate management or due to contribution of maternal
and fetal causes. This agrees with Bari W., et al) who observed
that perinatal death associated with obstetrical complications
as assisted delivery (186),but Sheiner E. et al) who disagree
with our study, observed that obstetrical problems had independent
associations with perinatal mortality (187).
The study results showed the high
rate of maternal mortality due to direct causes during pregnancy,
and in the (first 42 days) post partum. The common causes
were hypertensive disorders, postpartum hemorrhage, and thromboembolic
problems. These results are explained as, early death at first
42 days may be at labor or after a short time when the mother
is still in hospital, and is recorded as pregnancy related
death. But the lower rate of maternal mortality was in the
period (after 42days - 1year) of pregnancy termination. Berg
C.J., et al in the United States showed that the pregnancy
related mortality ratio increased, probably because of improved
identification of pregnancy related death, and common causes
were embolism, hemorrhage, and other medical conditions (188).
Meta-analysis provides an opportunity
to examine consistency of the results across studies, in relation
to quality of studies, and we can provide a plot of results
with only the best studies included and then with successive
inclusion of varying levels of quality, of the studies(115).
Our study showed that the common maternal mortality causes
were hypertensive disorders, and hemorrhagic complications
of pregnancy, in addition to embolism, sepsis, and cerebrovascular
accidents which were less frequent than the first two causes.
Maternal mortality ratio and causes
of our study compared with other studies: Gaym A), Sloan N.L.,
Langer A., Hernandez B., Romero M., and Winikoff B., and Berg
C., Chang J., Callaghan W.M., and Whitehead S.J. agreed with
our results that hemorrhage problems of pregnancy, hypertensive
disorders of pregnancy, and sepsis were mutual leading causes
of maternal mortality(188,189,190) . But Berg C.J., Chang
J., Callaghan W.M., and Whitehead S.J. agreed with our results
that embolism and cerebrovascular accidents form the leading
causes of maternal mortality (188).
CONCLUSIONS AND RECOMMENDATIONS
6.1.
Conclusions:
6.1.1. Safe fetus/baby and mother outcomes in relation to
maternal factors were found in married women, parity group
of (1-4), pregnancy spacing >2 years, good antenatal care,
mothers who attended both private clinics and primary health
care centers, low risk level, women received tonics during
pregnancy, and those who received tetanus immunization.
6.1.2. During labor, complications
decreased with hospital site of delivery, normal duration
of labor for both primiparous and multiparous women, and elective
cesarean section and forceps delivery were associated with
no complications.
6.1.3. Safe fetus/baby and mother,
in relation to fetal factors associated with full term babies
with normal birth weight, Rh +ve for both mother and baby,
regular fetal heart monitoring during labor, and single fetuses
pregnancy.
6.1.4. Male and female gender of
baby had nearly equal effect on safety of mothers and fetuses/babies.
6.1.5. Maternal and fetal/baby complications
mostly associated with maternal age group <16, >45 years,
illiterate mothers, rural living mothers, and these complications
mostly happened in ante partum period during recent pregnancy.
6.1.6. Perinatal mortality is most
common due to maternal causes.
6.1.7. Maternal mortality is most
common in the first (42) postpartum days due to direct causes.
6.1.8. Most common risk factors were
family history of medical diseases, previous cesarean section,
low birth weight babies, ante partum hemorrhage, and toxemia
in that order.
6.1.9. Maternal mortality happened
due to hypertensive disorders, and hemorrhagic problems of
pregnancy.
6.2. Recommendations:
6.2.1. Improve maternal health by:
a. Clean and safe delivery by skilled attendant at birth of
all mothers.
b. Community awareness of maternal health needs.
c. Improvement of health status of women.
d. Improve health professional performance.
e. Integrate referral hospital services into the existing
primary health care services.
f. Develop appropriate strategic polices for referral hospital
including antenatal, postnatal, family planning, and emergency
obstetric care.
g. Reporting system for domestic and other violence against
women.
h. Community awareness of family planning and advantage of
child spacing.
i. Laws and legislation for midwifery.
j. Continuing pre services and in services health education.
k. Strengthening monitoring system for maternal mortality.
6.2.2. Improve neonatal health by:
a. Quality care of the newborn babies by introduction of modern/new
technologies and, skilled staff.
b. Action oriented newborn death surveillance system.
c. Introducing early detection and management of hereditary
diseases.
d. Introduce genetic counseling services.
|
Table (1): Effect of maternal
factors on the mother, and on the fetus/newborn outcome.
|
| Factors |
Outcome |
| Safe |
Unsafe |
Total |
| |
No. |
% |
No. |
% |
No. |
% |
| *Maternal age |
|
|
|
|
|
|
| <16 years |
2 |
4.8 |
40 |
95.2 |
42 |
0.5 |
| 16-25year |
518 |
56.4 |
400 |
43.6 |
918 |
11 |
| 26-35years |
446 |
51.5 |
420 |
48.5 |
866 |
10.4 |
| 36-45years |
90 |
38.3 |
145 |
61.7 |
235 |
2.8 |
| >45years |
4 |
21.1 |
15 |
78.9 |
19 |
0.2 |
| *Educational level |
|
|
|
|
|
|
| Literate |
728 |
76 |
230 |
24 |
958 |
11.5 |
| Illiterate |
332 |
29.6 |
790 |
70.4 |
1122 |
13.5 |
| *Parity |
|
|
|
|
|
|
| Zero |
439 |
49.4 |
449 |
50.6 |
888 |
10.7 |
| 1-4 |
523 |
56.4 |
405 |
43.6 |
928 |
11.2 |
| ≥5 |
98 |
37.1 |
166 |
62.9 |
264 |
3.2 |
| *Marital state |
|
|
|
|
|
|
| Married |
1054 |
54.1 |
896 |
45.9 |
1950 |
23.4 |
| Divorced |
1 |
7.7 |
12 |
92.3 |
13 |
0.2 |
| Widowed |
2 |
5.3 |
36 |
94.7 |
38 |
0.5 |
| Separated |
3 |
3.8 |
76 |
96.2 |
79 |
0.9 |
| Subjects |
4240 |
3.8 |
76 |
96.2 |
79 |
0.9 |
P value less
than 0.001D.F=14
<<
Back to text
|
Table (2): Effect of fetal
factors on the mother, and on the fetus/newborn outcome.
|
| Fetal
factors |
Outcome
|
| Safe
|
Unsafe
|
Total |
| No. |
% |
No. |
% |
No. |
% |
| *No. of fetuses
|
|
|
|
|
|
|
| Single |
1068 |
54.5 |
892 |
45.5 |
1960 |
32 |
|
Multiple
|
13 |
16.2 |
67 |
83.8 |
80 |
1.3 |
| *Gender |
|
|
|
|
|
|
| Male |
540 |
53 |
478 |
47 |
1018 |
16.6 |
| Female |
541 |
53 |
481 |
47 |
1022 |
16.7 |
| *Weight |
|
|
|
|
|
|
| Extreme LBW<1000gm
|
0 |
0 |
3 |
100 |
3 |
0.1 |
| Very LBW<1500gm
|
0 |
0 |
74 |
100 |
74 |
1.2 |
| LBW<2500gm |
0 |
0 |
134 |
100 |
134 |
2.2 |
| Normal (2500-4000)gm
|
1080 |
61.3 |
681 |
38.7 |
1761 |
28.8 |
| Macrosomia >4000gm
|
1 |
1.5 |
67 |
98.5 |
68 |
1.1 |
| Subjects |
3243 |
53 |
2877 |
47 |
6120 |
100 |
|
Figure (2): Effect of parental
consanguinity on fetus/newborn outcome.
|
<<
Back to text
|
Table (3): Effect of antenatal
care (ANC) on the mother, and on the fetus/newborn outcome.
|
|
ANC
|
Outcome
|
|
Safe
|
Unsafe
|
Total
|
|
|
No.
%
|
No.
%
|
No.
%
|
|
Good (>5 visits)
|
939
|
68.9
|
424
|
31.1
|
1363
|
65.5
|
|
Poor (<5 visits)
|
108 |
17.6 |
506 |
82.4 |
614 |
29.5 |
|
None
|
13 |
12.6 |
90 |
87.4 |
103 |
5 |
|
Subjects
|
1060 |
51 |
1020 |
49 |
2080 |
100 |
|
Chi square=509.6 Degree of freedom=2
|
<< Back to text
|
Table (4): Effect of ANC
site on the mother and on the fetus/newborn outcome.
|
|
Site of ANC |
Outcome
|
|
Safe
|
Unsafe
|
Total
|
|
No.
|
%
|
No.
|
%
|
No.
|
%
|
|
Private
|
548 |
57.6 |
403 |
42.4 |
951 |
48.1 |
|
PHCC
|
185 |
33.3 |
371 |
66.7 |
556 |
28.1 |
|
Both
|
314 |
66.8 |
156 |
33.2 |
470 |
23.8 |
|
Subjects
|
1047 |
53 |
930 |
47 |
1977 |
100 |
|
Chi square=89.8 Degree of freedom=2
|
|
Table (5): Effect of maternal
immunization with tetanus toxoid on the mother and
the fetus/newborn outcome.
|
|
Immunization
|
Outcome
|
| Safe |
Unsafe |
Total |
| No. |
% |
No. |
% |
No. |
% |
| *Received |
|
|
|
|
|
|
| -Complete |
422 |
86.5 |
66 |
13.5 |
488 |
23.5 |
| -Partial |
500 |
58.7 |
352 |
41.3 |
852 |
41 |
| *Not received |
138 |
18.6 |
602 |
81.4 |
740 |
35.5 |
| Subjects |
1060 |
51 |
1020 |
49 |
2080 |
100 |
|
Chi square= 576 Degree of freedom=
2
|
<< Back to text
|
Table (6): Effect of birth
spacing (average spacing period among all pregnancies)
on the mother and the fetal/newborn outcome.
|
| Complications
|
Period of spacing
|
| <2years
|
>2years
|
Subjects
|
| No. |
% |
No. |
% |
No. |
% |
| Both safe |
340 |
35.2 |
720 |
64.6 |
1060 |
51 |
|
Both unsafe
|
135 |
14 |
68 |
6.1 |
230 |
9.7 |
|
SmUb
|
123 |
12.7 |
74 |
6.7 |
197 |
9.5 |
|
UmSb
|
368 |
38.1 |
252 |
22.6 |
620 |
29.8 |
|
Total
|
966 |
46.4 |
1114 |
53.6 |
2080 |
100 |
|
Chi square= 182.5 Degree of freedom=
3
|
|
Figure (4): Duration of
pregnancy and outcome of the mother, and the fetus/newborn.
|
SmUb=Safe mother
and unsafe baby. UmSb=Unsafe mother and safe baby.
|
<< Back to text
|
Table (7): Effect of abortion
types (11, 31) on maternal safety.
|
|
Types
|
Outcome
|
| Safe
|
Unsafe
|
Total
|
| No. |
% |
No. |
% |
No. |
% |
| *Spontaneous |
|
|
|
|
|
|
|
-Threatened
|
24
|
92.3
|
2
|
7.7
|
26
|
22
|
|
-Inevitable
|
6
|
100
|
0
|
0
|
6
|
5.1
|
|
-Incomplete
|
20
|
80
|
5
|
20
|
25
|
21.2
|
|
-Complete
|
12
|
66.7
|
6
|
33.3
|
18
|
15.3
|
|
-Missed
|
2
|
25
|
6
|
75
|
8
|
6.8
|
|
-Habitual
|
4
|
28.6
|
10
|
71.4
|
14
|
11.8
|
|
-Septic
|
1
|
10
|
9
|
90
|
10
|
8.5
|
| *Therapeutic |
8
|
72.7
|
3
|
27.3
|
11
|
9.3
|
| Subjects |
77
|
65.3
|
41
|
34.7
|
118
|
100
|
|
Chi square=41.4 Degree of freedom=7
|
<< Back to text
|
Table (8): Effect of delivery
site on the mother and on the fetus/newborn outcome.
|
|
Site of delivery
|
Outcome
|
|
Both safe
|
Both unsafe
|
UmSb
|
SmUb
|
Subjects
|
|
No.
|
%
|
No.
|
%
|
No.
|
%
|
No.
|
%
|
No.
|
%
|
|
*Hospital
|
1017
|
55.8
|
125
|
6.9
|
586
|
32.2
|
94
|
5.1
|
1822
|
93
|
| **HomeBy:- |
|
|
|
|
|
|
|
|
|
|
| Registered midwife
|
43
|
62.3
|
0
|
0
|
0
|
0
|
26
|
37.7
|
69
|
3.5
|
| Non registered
midwife |
0
|
0
|
30
|
46.9
|
34
|
53.1
|
0
|
0
|
64
|
3.3
|
| Not aided at
all |
0
|
0
|
5
|
100
|
0
|
0
|
0
|
0
|
5
|
0.2
|
| Total |
1060
|
54.1
|
160
|
8.2
|
620
|
31.6
|
120
|
6.1
|
1960
|
100
|
|
Chi square= 455.5 Degree of freedom=
9
|
Table (9): Relation of mode of delivery and
(intra-partum -postpartum) on the mother and the fetus/newborn
complications.
|
| Mode
of delivery |
Complications
|
| +ve
|
-ve
|
Total
|
|
No.
|
%
|
No.
|
%
|
No.
|
%
|
| *Spontaneous vaginal
delivery |
461
|
53.5
|
400
|
46.5
|
861
|
42.2
|
| *Induced vaginal
delivery |
289
|
61.8
|
179
|
38.2
|
468
|
22.9
|
| *C/S |
|
|
|
|
|
|
| -Emergency |
145
|
81
|
34
|
19
|
179
|
8.8
|
| -Elective |
30
|
9.1
|
300
|
90.9
|
330
|
16.2
|
| *Instrumental |
|
|
|
|
|
|
| -Forceps |
34
|
16.8
|
168
|
83.2
|
202
|
9.9
|
| -Vacuum |
0
|
0
|
0
|
0
|
0
|
0
|
| Subjects |
959
|
47
|
1081
|
53
|
2040
|
100
|
|
Chi square= 403.2 <'>Degree of freedom=
5
|
<< Back to text
|
Table (10): Effect of labor
duration (11) on the mother and the fetus/newborn
outcome.
|
| Outcome
|
Primigravida
|
Multigravida
|
Subjects
|
|
<20 hours
|
<20
hours
|
<14 hours
|
>14 hours
|
|
|
No.
|
%
|
No.
|
%
|
No.
|
%
|
No.
|
%
|
No.
|
%
|
|
Safe
|
377
|
79.9
|
91
|
39.6
|
433
|
73
|
40
|
13.8
|
941
|
59.4
|
|
Unsafe
|
95
|
20.1
|
139
|
60.4
|
160
|
27
|
250
|
86.2
|
644
|
40.6
|
|
Total
|
472
|
29.8
|
230
|
14.5
|
593
|
37.4
|
290
|
18.3
|
1585
|
100
|
|
Chi square= 415.4 <'>Degree of freedom=
3
|
|
Table (11): Type of fetal monitoring
during labor and perinatal complications.
|
| Fetal
monitoring |
Perinatal
complications |
|
+ve
|
-ve
|
Total
|
|
N0.
|
%
|
No.
|
%
|
No.
|
%
|
|
*Regular fetal
heart monitoring
|
223
|
20.9
|
844
|
79.1
|
1067
|
78.5
|
|
*Partogram
|
20
|
6.8
|
273
|
93.2
|
293
|
21.5
|
|
*Fetal PH estimation
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Subjects
|
243
|
17.9
|
1117
|
82.1
|
1360
|
100
|
|
Chi square= 31.1 <'>Degree of freedom=
2
|
<< Back to text
|
Table (12): Effect of maternal
Rh on the fetus/newborn outcome.
|
|
Rh of mother
|
Outcome
|
| Safe
|
Unsafe
|
Total
|
| No. |
% |
No. |
% |
No. |
% |
| Rh +ve |
1480
|
89.2
|
180
|
10.8
|
1660
|
84.7
|
| Rh-ve mother
(Rh+ve baby) |
78
|
48.4
|
83
|
51.6
|
161
|
8.2
|
| Rh-ve mother
(Rh-ve baby) |
122
|
87.8
|
17
|
12.2
|
139
|
7.1
|
| Subjects |
1680
|
85.7
|
280
|
14.3
|
1960
|
100
|
|
Chi square= 199.2 Degree of freedom=2
|
|
Table (13): Maternal death
and its causes.
|
| Causes
|
Maternal
death |
Subjects
|
|
No.
|
%
|
No.
|
%
|
| * First 42 days |
|
|
|
|
| -Direct |
5
|
45.4
|
5
|
45.4
|
| -Indirect |
2
|
18.2
|
2
|
18.2
|
| *After 42days-1
year |
|
|
|
|
| -Direct |
1
|
9.1
|
1
|
9.1
|
| -Indirect |
1
|
9.1
|
1
|
9.1
|
| *Coincidental |
2
|
18.2
|
2
|
18.2
|
|
Total
|
11
|
100
|
11
|
100
|
<<
Back to text
Table (14): complications outcome
|
| Time
|
Complications
|
|
Mother
|
Fetal/newborn
|
Subjects
|
|
No.
|
%
|
No.
|
%
|
No.
|
%
|
| *Ante partum |
|
|
|
|
|
|
| -1st trimester |
280
|
24.3
|
93
|
20.9
|
373
|
23.4
|
| -2nd trimester |
231
|
20.1
|
15
|
3.4
|
246
|
15.4
|
| -3rd trimester
|
369
|
32.1
|
25
|
4.9
|
391
|
24.5
|
|
*Intrapartum
|
129
|
11.2
|
150
|
33.6
|
279
|
17.5
|
|
*Postpartum
|
|
|
|
|
|
|
|
-Early:
|
|
|
|
|
|
|
| -1st 24 hour |
56
|
4.9
|
142
|
31.8
|
198
|
12.4
|
| -After 24 hour |
34
|
2.9
|
8
|
1.8
|
42
|
2.6
|
|
-Late:
|
|
|
|
|
|
|
| -Before end of 42 day
|
48
|
4.2
|
16
|
3.6
|
64
|
4
|
| -After 42 days-1st
year |
30
|
0.3
|
0
|
0
|
3
|
0.2
|
|
Total
|
1150
|
72.1
|
446
|
27.9
|
1596
|
100
|
|
Chi square= 440.9 <'>Degree of freedom=
7
|
<<
Back to text
Table (15): Effect of maternal drug history
on the mother and the fetus/newborn outcome.
|
|
Drug history
|
Outcome
|
|
Both safe
|
Both unsafe
|
SmUb
|
UmSb
|
Total
|
|
No.
|
%
|
No.
|
%
|
No.
|
%
|
No.
|
%
|
No.
|
%
|
| *Preconcep-
tional preventive drugs |
|
|
|
|
|
|
|
|
|
|
| -Harmful |
0
|
0
|
0
|
0
|
7
|
100
|
0
|
0
|
7
|
0.4
|
| -Harmless |
60
|
84.5
|
11
|
15.5
|
0
|
0
|
0
|
0
|
71
|
2.9
|
| *Antepartum
|
|
|
|
|
|
|
|
|
|
|
| -Tonics |
948
|
64.9
|
0
|
0
|
20
|
1.4
|
492
|
33.7
|
1460
|
60.5
|
| -Drug for specific
disease |
305
|
59
|
36
|
6.9
|
64
|
12.4
|
112
|
21.7
|
517
|
21.4
|
| *Intraparum |
|
|
|
|
|
|
|
|
|
|
| -Antihype- tensive |
2
|
2.9
|
43
|
61.4
|
19
|
27.1
|
6
|
8.6
|
70
|
2.9
|
| -Oxytocic drugs |
182
|
70.3
|
56
|
21.6
|
18
|
6.9
|
3
|
1.2
|
259
|
10.7
|
| -Anticon- vulscent
|
1
|
3.3
|
17
|
56.7
|
0
|
0
|
12
|
40
|
30
|
1.2
|
| Subjects |
1498
|
62
|
163
|
6.8
|
128
|
5.3
|
625
|
25.9
|
2414
|
100
|
|
Chi square= 787.1 Degree of freedom=21
|
|
Both safe
|
Both unsafe
|
SmUb
|
UmSb
|
Total
|
|
No.
|
%
|
No.
|
%
|
No.
|
%
|
No.
|
%
|
No.
|
%
|
|
*Medical
diseases
|
|
|
|
|
|
|
|
|
|
|
|
-Acute
illnesses
|
51
|
38.6
|
35
|
26.5
|
18
|
13.7
|
28
|
21.2
|
132
|
5.3
|
|
-Chronic
illnesses
|
80
|
20.4
|
165
|
42
|
43
|
10.9
|
105
|
26.7
|
393
|
15.7
|
|
*Surgical
operations
|
|
|
|
|
|
|
|
|
|
|
|
-Gynecological
& obstetrical
|
115
|
28.5
|
46
|
11.4
|
2
|
0.5
|
240
|
59.6
|
403
|
16
|
|
-Non
gynec-ological
|
86
|
52.1
|
8
|
4.8
|
11
|
6.7
|
60
|
36.4
|
165
|
6.6
|
|
*
Family history
|
|
|
|
|
|
|
|
|
|
|
|
-Inherited
disorders
|
14
|
19.2
|
9
|
12.3
|
43
|
58.9
|
7
|
9.6
|
73
|
2.9
|
|
-Multiple
pregnancy
|
190
|
78.2
|
18
|
7.4
|
4
|
1.6
|
31
|
12.8
|
243
|
9.7
|
|
-Medical
diseases
|
648
|
59
|
65
|
5.9
|
36
|
3.3
|
350
|
31.8
|
1099
|
43.8
|
|
Subjects
|
1184
|
47.2
|
346
|
13.8
|
127
|
6.3
|
821
|
32.7
|
2508
|
100
|
|
Chi square= 907.3 Degree
of freedom=18
|
Back
to text
|
Table (16): Comparison among
risk factors of pregnant women and outcome of mother
and fetus/newborn.
|
|
Risk Factors
|
Outcome
|
|
Safe
|
Unsafe
|
Total
|
|
No.
|
%
|
No.
|
%
|
No.
|
%
|
|
*Age<16, >45years
|
6
|
9.8
|
55
|
90.2
|
61
|
1.2
|
|
*Parity >5
|
98
|
37.1
|
166
|
62.9
|
264
|
5.3
|
|
*>=2 abortion or history of infertility or PPH
|
112
|
38.4
|
180
|
61.6
|
292
|
5.9
|
|
*Toxemia or hypertension
|
154
|
44.6
|
191
|
55.4
|
345
|
7
|
|
*Previous C\S
|
40
|
9.4
|
386
|
90.6
|
426
|
8.6
|
|
*Abnormal or difficult labor
|
7
|
17.9
|
32
|
82.1
|
39
|
0.8
|
|
*Child <5 lb, >9 lb
|
8
|
2.7
|
292
|
97.3
|
300
|
6.1
|
|
*Gestational diabetes
|
5
|
20
|
20
|
80
|
25
|
0.5
|
|
*Chronic renal diseases
|
1
|
8.3
|
11
|
91.7
|
12
|
0.2
|
|
*Cardiac diseases
|
0
|
0
|
18
|
100
|
18
|
0.4
|
|
*Previous gynecological surgery
|
26
|
37.7
|
43
|
62.3
|
69
|
1.4
|
|
*Other significant medical diseases
|
10
|
12.2
|
72
|
87.8
|
82
|
1.7
|
|
**For present pregnancy
|
|
|
|
|
|
|
|
**Bleeding >20 wk, <20wk of gestation
|
91
|
31.6
|
197
|
68.4
|
288
|
5.8
|
|
Anemia <10 g/l
|
199
|
58.9
|
139
|
41.1
|
338
|
6.8
|
|
**Postmaturity
|
80
|
53
|
71
|
47
|
151
|
3.1
|
|
**Hypertension
|
176
|
55.3
|
142
|
44.7
|
318
|
6.4
|
|
**PROM
|
28
|
37.8
|
46
|
62.2
|
74
|
1.5
|
|
**I.U.G.R.
|
0
|
0
|
168
|
100
|
168
|
3.4
|
|
**Polyhydramnios
|
22
|
26.5
|
61
|
73.5
|
83
|
1.8
|
|
**Multiple pregnancy
|
10
|
25
|
30
|
75
|
40
|
0.8
|
|
**Breech or malpresentation
|
25
|
23.8
|
80
|
76.2
|
105
|
2.1
|
|
**Isoimmunization
|
78
|
48.4
|
83
|
51.6
|
161
|
3.2
|
|
***Others
|
|
|
|
|
|
|
|
***Weight <45kg,>90kg
|
12
|
22.2
|
42
|
77.8
|
54
|
1.15
|
|
***Height<150 cm
|
18
|
34.6
|
34
|
65.4
|
52
|
1.05
|
|
***Family history of Inherited disorders
|
14
|
18.2
|
63
|
81.8
|
77
|
1.6
|
|
***Family history of medical diseases
|
648
|
59
|
451
|
41
|
1099
|
22.2
|
|
Subjects
|
1868
|
37.4
|
3073
|
62.6
|
4941
|
100
|
<< Back to text
|
Table (17): The characteristics
of included studies.
|
|
Study
|
Method
|
Population
|
Outcome
|
|
1. Asheber Gaym, 2000
|
A retrospective study of hospital maternal death
at Jima hospital, Southwestern Ethiopia for 9 years
(September 1990-May 1999)
|
Both direct and indirect maternal death during pregnancy,
or delivery or within 42 days of pregnancy termination
according to WHO definition.
|
Maternal mortality ratio=1965 per 100 000 live births.
|
Common causes of maternal deaths:
1. Obstructed labor=45.5%.
2. Sepsis=40%.
3. Ruptured uterus=33.2%.
4. Haemorrhagic complications of pregnancy=11.1%.
5. Hypertensive disorders =3.8%.
|
|
2. Sloan N.L., Langer A., Hernandez B., Romero
M., and
Winikoff B., 2001.
|
Retrospective study on maternal deaths on autopsy
in Mexico, at 1995.
|
Autopsy of died mothers due to direct and indirect
maternal death according to WHO definition.
|
Maternal mortality ratio=53 per 100 000 live births.
|
1. Hypertensive disorders= 64.6%.
2. Hemorrhagic complications of pregnancy=51.9%.
3. Sepsis= 18.5%.
4. Obstructed labor=9.7%.
5. Abortion= 5.5%.
|
|
3. Berg C.J., Chang J., Callaghan W.M., Whitehead
S.J., 2001.
|
A retrospective study in United State, 1991-1997.
|
Both direct and indirect maternal deaths according
to WHO definition.
|
Maternal mortality ratio=12 per 100 000 live birth.
|
1. Thromboembolic complications=19%.
2. Hemorrhagic complications of pregnancy=18%.
3. Hypertensive disorders of pregnancy=16%.
4. Sepsis= 13%.
5. Cardiomyopathy= 7%..
|
|
4. Our study.
|
A retro prospective study in Tikrit General Teaching
Hospital, at 2005-2006 (November 2005-April 2006).
|
Both direct and indirect maternal deaths according
to WHO definition.
|
Maternal mortality ratio=161 per 100 000 live birth.
|
1. Hypertensive disorder=28.6%.
2. Haemorrhagic disorder of pregnancy=28.6%.
3. Embolism=14.3%.
4. Sepsis=14.3%.
5. Cerebrovascular accident=14.3%.
|
 |
REFERENCES
- 1. World Health Organization.
Reproductive health research. WHO,Geneva, 2002:25-26.
2. World Health Organization. Safe Motherhood Report.
WHO, Geneva, 2006.
3. MICS Survey 2000, CSO/Iraq, MOH Statistics Section,
NRI in MOH of Iraq, UNICEF, ICMMS/ Iraq, 1999.
4. Salah Al-Deen health office. Statistical records,
2005.
5. Tikrit General Teaching Hospital Statistical Records,
2005.
6. Tinker, Anue, and Koblinsky M. Making motherhood safer
world bank discussion paper 202. Washington,1. World Health
Organization. Reproductive health research. WHO, Geneva,
2002:25-26.
2. World Health Organization. Safe Motherhood Report.
WHO, Geneva, 2006.
3. MICS Survey 2000, CSO/Iraq, MOH Statistics Section,
NRI in MOH of Iraq, UNICEF, ICMMS/ Iraq, 1999.
4. Salah Al-Deen health office. Statistical records,
2005.
5. Tikrit General Teaching Hospital Statistical Records,
2005.
6. Tinker, Anue, and Koblinsky M. Making motherhood safer
world bank discussion paper 202. Washington, World Bank;
1993.
7. WHO Regional office for South East Asia. Safe motherhood
Report, WHO, 2006.
8. Brannigan R.E., and Lipshultz L.I. Sperm transport
and capacitnation. In: Sciarra J.J., and Watkins T.J.
Gynecology and obstetrics. Vol.5. Philadelphia, Lippincott
Williams and Wilkins; 2000: 3.
9. Cunningham F.G., Grant N.F., Leveno K.J., et al. Williams
obstetrics. 21st edition. New York, MC Graw-Hill; 2001:221-230.
10. Sekhri R., Kate C., Stephen N. Prescription for the
Boards USMLE step2. First edition. United State of America,
Little brown and company; 1996: 203-235.
11. Neville F., and Moore G. Essential of obstetrics
and gynecology. 2nd edition. United State of America.,
Saunders Company; 1992: 24, 120-194,294,628.
12. Chamberlain G.V.P. Obstetrics. 16th edition. London,
British Library; 1995: 102-105, 298-300.
13. Salder T.W. Langman`s medical embryology. 8th edition.
Philadelphia, Lippincott Williams and Wilkins; 2000: 173.
14. World Health Organization. Safe motherhood Report.
WHO, Geneva, In 7th April 1998.
15. Arias F. Practical guide to high risk pregnancy and
delivery. United State of America, Mosby-year book; 1993:4,55-81.
16. Ralph C. Current obstetric and gynecologic diagnosis
and treatment. 4th edition. California, Lange medical
publication; 1982: 616.
17. Ralph C. Handbook of obstetrics and gynecology. 7th
edition. California, Lange medical publication; 1980:103-128.
18. Maternal, Child, and Reproductive Health Strategy
in Iraq (2005-2008). Iraq, Ministry of Health, 2004.
19. Rachel A., and Royce. Birth spacing the long and
short of it. Journal of the American Medical Association.
2006; 295(15): 1837.
20. Eliakin R., Abulafia O., and Sherer D.M. Hyperemesis
Gravidarum. A current Review. American Journal of Perinatalogy.
2000; 17(4):207-210.
21. Power M.L., Holzman G.B., and Schulkin J. A survey
on the management of nausea and vomiting in pregnancy
by obstetrician and gynecologists. Primary care update
for Obstetric/Gynecology. 2001; 8(2):69-72.
22. American College of Obstetricians and Gynecologists
(ACOG). Gestational diabetes (ACOG Practice Bulletin No.30).
Washington, DC: Author.2001a.
23. Reece E.A. The history of diabetes mellitus. In:
Reece E.A., and Cousten D.P. Diabetes mellitus in pregnancy.
New York, Churchill Livingstone; 1995: 7.
24. Queenan J.T. Management of high risk pregnancy. 4th
edition. United State of America, Black well science;
1999:368.
25. Israel High-Tech and Investment. Report ,May 2005.
26. Mushburn J. Ectopic Pregnancy. Triage do`s and don`ts.
Journal of Nurse Midwifery. 1999; 44(6):550.
27. Stovall T.G., Ling F.W., Gray L.A., Carson S.A.,
and Buster J.E. Methotrexate treatment of unruptured ectopic
pregnancy: A report of 100 cases. Obstetric and Gynecology.
1991; 77: 749.
28. Edmonds D.K. Dewhurst`s Textbook of Obstetrics and
Gynecology for postgraduates. 6th edition. London, Blackwell
Science; 1999: 96-97.
29. Gracia C.R., and Barnhart K.T. Diagnosing ectopic
pregnancy. Obstetrics and gynecology. 2001; 97(3):465.
30. Lipscomb G.H., Stovall T.G., and Ling F.W. Non surgical
treatment of ectopic pregnancy. New England Journal of
Medicine. 2000; 343(18): 1327.
31. Rosevear S. Bleeding in early pregnancy. In: James
D.K., Steer P.J., Weiner C.P., Gonik B. High risk pregnancy
management options. 2nd edition, Philadelphia., W.B. Saunders;
1999: 1150.
32. Olds S.B., Marcia L., and Davidson M.R. Maternal-New
born Nursing and womens` health care. 7th edition. United
State of America, Prentice Hill; 2004:469, 506, 721, 951.
33. Ashworth F. Septic abortion. In: Stabile I., Grudzinskas
J.G., and Chard T. Spontaneous abortion: Diagnosis and
treatment. London, Springer Verlag; 1992: 119.
34. Anderson N., Wolfhardt J., Christens P., Olsen J.,
and Mellbye M. Maternal age and fetal loss. British medical
Journal. 2000; 320: 1709-1710.
35. Report. Maternal and child morbidity and mortality
in Egypt. Egypt, 2003.
36. Budd C., and Gardiner M. Paediatrics. Harcourt Brace
and company limited; 1999:86-91, 213-221.
37. Edwards R.K., Locksmith .J., and Duff P. Expanded
spectrum antibiotics with preterm, premature rupture of
membranes. Obstetrics and gynecology. 2000; 96(1): 63.
38. Hannah M.E., Ohlssson A., Farine D., et al. Induction
of labor compared with expectant management for pre labor
rupture of the membranes at term. New England Journal
of Medicine. 1996; 3349: 1007.
39. Chitkara U., and Berkowitz R.L. Multiple gestation.
In: Grabbe S.G., Neiebyl G.R., and Simpson J.L. Obstetrics
(Normal and problem pregnancies). 4th edition. New York,
Churchill Livingstone; 2002: 101-104.
40. Martin N.G., Shanley S., Butt K., Osborne J., and
O`Brein G. Excessive follicular recruitment and growth
in mothers of spontaneous dizygotic twins. Acta. Genetic
Medicine Gemellol Roma. 1991; 40: 291-301.
41. Petterson B., Nelson K.B., Waston L., and Stanley
F. Twins, triplets, and cerebral palsy in birth in Western
Australia in the 1980s. British Medical Journal. 1993;
307: 1239.
42. Berkowitz R.S., and Goldstein D.P. Gestational trophoblastic
disease. Cancer. 1995; 76: 675.
43. Smith D.B., O`Reilly S.M., and Newlands E.S. Current
approaches to diagnosis and treatment of gestational trophoblastic
disease. Journal of Ultrasound Medicine. 1993; 12:59.
44. Crowley P. Corticosteroids prior to preterm delivery.
In: Keirse M.J., Renfrew M.J., Neilson J.P., and Crowther
C. Pregnancy and childbirth database (database on disc
and CD-ROM). Oxford, Update software; 1995.
45. Cram L.F., Zapata M.I., Joy E.C., and Baker B. Genitourinary
infection and their association with preterm labor. American
family physician. 2002; 25: 295.
46. Smith L.G., and Duff P. Infection, antibiotics, and
preterm delivery: Seminars in perinatology. 2001; 25:
295.
47. Lewis G., et al. Report on confidential Enquiries
into maternal deaths in the U.K. 1994-1996. London, HMSO;
1998. 48. Harrison K.A., and Rossiter C.E. Maternal mortality.
British Journal of Obstetric/ Gynecology. 1985; 5: 102.
48. Harrison K.A., and Rossiter C.E. Maternal mortality.
British Journal of Obstetric/ Gynecology. 1985; 5: 102.
49. Neilson J.P. Perinatal loss and appropriate fetal
surveillance. In: Geijn H.P., and Copray F.J.A. A critical
appraisal of fetal surveillance. Amsterdam, Elsevier Science
B.V.; 1994: 17.
50. Hegan R., Benninger H., Chiffings D., Evans S., and
French N. Very preterm birth-a regional study-part 1:
Maternal and obstetric factors. British Journal of Obstetric/
Gynecology. 1996; 103: 233.
51. Palmer L., Blair E., Petterson B., and Burton P.
Antenatal antecedents of moderate and severe cerebral
palsy. Paediatric Perinatal Epidemiology. 1995; 9: 171.
52. Wolf E.J., Mallozzi A., Rodis J.F., Ean J.F.X., Vintzileos
A.M., and Campbell W.A. Placenta previa is not an independent
risk factor for a small for gestational age infant. Obstetric/
Gynecology. 1991; 77:707.
53. Love C.D., and Wallace E.M. Pregnancies complicated
by placenta previa. What is appropriate management. British
Journal of Obstetric/ Gynecology. 1996; 103: 864.
54. Wing D.A., Paul R.H., and Millar L.K. Management
of the symptomatic placenta previa a randomized controlled
trial of inpatient versus outpatient expectant management.
American Journal of Obstetric/ Gynecology. 1996; 175:
806-7.
55. Gaufberg S. Abruptio placentae. English Medical Journal.
2001; 2(3):10.
56. Pearlman M.D., Tintinalli J.E., and Lorenz R.P. A
prospective controlled trial of outcome after trauma during
pregnancy. American Journal of Obstetric/ Gynecology.
1990; 162:1502.
57. Rice J.P., Kay H.H., and Mahony B.S. The clinical
significance of uterine leiomyomas in pregnancy. American
Journal of Obstetric/ Gynecology. 1989; 160: 1212.
58. Kramer M.S., Usher R.H., Pollack R., Boyd M., and
Usher S. Etiologic determinants of abruption placentae.
Obstetric/ Gynecology. 1997; 81: 221.
59. Miller J.M., Boudereaux M.C., and Regan F.A. A case
control study of cocain use in pregnancy. American Journal
of Obstetric/ Gynecology. 1990; 162: 1502.
60. Rasmussen S., Irgens L.M., Bergsjo P., and Dalaker
K. Perinatal mortality and case fatality after placental
abruption in Norway 1967-1991. Acta Obstetric/ Gynecology
Scand. 1996; 75: 229.
61. Keeling J.W. Macerated stillbirth. In: Keeling J.W.
Fetal and neonatal pathology. Berline, Springer-Verlag;
1987: 167.
62. Fischer R.L., Kuhlman K., Grover J., Montgomery O.,
and Wapner R.J. Chronic, massive fetomaternal hemorrhage
treated with repeated fetal intravascular transfusions.
American Journal of Obstetric/ Gynecology. 1990; 162:
203.
63. Challis J.R.G. Characteristics of parturition. In:
Resnick R., Creasy R.K., and Bralow L. Maternal-fetal
medicine. 4th edition. Philadelphia, Saunders; 1999: 484.
64. Demelin L. La Contraction Uterine Etles Discineses
Correlative. Paris, Dupont; 1927.
65. King T. Labor pain in 21st century. Journal of Midwifery
and Womens` Health. 2002; 47(2): 68.
66. Ashe D. From positive to parenthood. Nursing Management.
2000; 31(10):30-31.
67. Swaim L.S., and Creasy R.K. Fetal assessment and treatment
during labor. In: Creasy R.K. Management of labor and
delivery. Malden MA, Blackwell; 1997: 164.
68. Philpott R.H., and Castle W.M. Cervicographs in the
management of labour in the primigravida.1.: The alert
line for detecting abnormal labour. Journal of Obstetric
and Gynecology British Cmmw. 1972; 79:592.
69. Philpott R.H., and Castle W.M. Cervicographs in the
management of labour in the primigravida.2.: The Action
line and treatment o abnormal labour. Journal of Obstetric/
Gynecology British Cmmw. 1972; 75: 599.
70. American College of Obstetricians and Gynecologists(ACOG).
Induction of labor (ACOG practice Bulletin No. 10). Washington,
Author; 1999.
71. Rosen T.S., and Batman D.A. Infants of addicted mothers.
In: Fanaroff A.A., and Martin R.J. Neonatal-Perinatal
medicine: Diseases of the fetus and infants. 7th edition.
United State of America, Mosby; 2002: 666.
72. Johanson R.B., and Menon V. Vacuum extraction versus
forceps delivery. In: Neilson J.P., Crowther C., Hodnett
E.D., et al. Pregnancy and Childbirth Module of the Cochrane
Database of Systematic Reviews. Oxford, Update Software;
1997.
73. Chenoy R., and Johanson R. A randomized prospective
study comparing deliver with metal and silicone rubber
vacuum extractor cups. British Journal of Obstetric/ Gyencology.
1992; 99: 360.
74. Sachs B.P., Kobelin C., Castro M.A., and Frigoletto
F. Sounding board: The risks of lowering cesarean-delivery
rate. New England Journal of Medicine. 1999; 340:55.
75. Grant A., Penn Z.J., and Steer P.J. Elective or selective
cesarean delivery of the small baby? A systematic review
of the controlled trials. British Journal Obstetric/ Gynecology.
1996; 103:1197.
76. Chdha Y.C., Mahmood T.A., Dick M.J. Smith N.C., and
Campbell D.M. Breech delivery and epidural analgesia.
British Journal Obstetric/ Gynecology. 1992; 99:97.
77. Dunlop W. The puerperium. Fetal Medicine Review.
1989; 1: 43.
78. World Health Organization (WHO). The prevention and
management of postpartum haemorrhage. Report of a technical
working group. Geneva; WHO: 1990.
79. Anderson H.F., and Hopkins M.p. Postpartum hemorrhage.
In: Sciarri J.J. Gynecology and obstetrics. Vol.2. 2002:
7.
80. Benedetti T.J. Obstetrics hemorrhage. In: Gabbe S.G.,
Niebyl J.R., and Simpson J.L. Obstetrics: Normal and problem
pregnancies. 4th edition. 2002: 503-538.
81. Roberts W.E. Emergent obstetric management of postpartum
hemorrhage. Obstetric/ Gynecology Clinical in North of
America. 1995; 22: 283.
82. Department of Health. Report on Confidential Enquiries
into maternal deaths in the United Kingdom 1988-1990.
London, HMSO; 1994.
83. Toppenberg K.S., and Black W.A. Uterine rupture:
What family physicians need to know. American family physician.
2002; 66(3):826.
84. Alexander J.D., and Schneider F.D. Vaginal bleeding
associated with pregnancy. Primary care. 2000; 27(1):
140.
85. Gilbert E.S., and Harman J.S. Manual of high risk
pregnancy and delivery. 3rd edition. United State of America,
Mosby; 2003: 201-205.
86. Cash J.C., and Glass C.A. Family practice guidelines.
Philadelphia, Lippincott; 2000: 8-11.
87. Baxley E.G. Postpartum biomedical concerns. Section
B postpartum endometritis. In: Ratcliffe S.D., Baxley
E.G., Byrd J.E., and Sakornbut E.L. Family practice obstetrics.
2nd edition. Philadelphia, Hanley and Belfus; 2001: 602-604.
88. Bowes W.A., and Katz V.L. Obstetrics: Normal and problem
pregnancies. 4th edition. New York, Churchill Livingstone;
2002: 712-716.
89. Meighan M., Davis M.W., Thomas S.P., and Droppleman
P.G. Living with postpartum depression: The father`s perspective.
American Journal of Maternal child Nursing. 2000; 24(4):
202-204.
90. Gjerdinger D., and Byrd J.E. Postpartum psychosocial
concerns. In: Ratcliff S.D., Baxley E.G., Byrd J.E., and
Sakornbut E.L. Family practice obstetrics.2nd edition.
Philadelphia, Hanley and Belfus; 2001: 626.
91. Report on confidential enquiries into maternal death
in United Kingdom. 2004: 9-215.
92. Cynthia J., and Berg M.D. Centers for disease control
and prevention. Atlanta.
128. Begaud B. Dictionary of pharmacoepidemiolog. New
York, John Wiley and Sons; 2000: 90.
93. Blackburn S.T. Maternal, fetal and neonatal physiology:
A clinical perspective.2nd edition. United State of America,
Saunders; 2003: 605.
94. Fanaroff A.A., and Martin R.J. Neonatal-Perinatal
Medicine Diseases of the fetuses and infants. 5th edition.
Vol.2. United State of America, Mosby-year book; 1992:
835.
95. Edwards M.S. Postnatal bacterial infection. In: Fanaroff
A.A., and Martin R.J. Neonatal-Perinatal medicine: Diseases
of the fetus and infant. 7th edition. Vol.2. United State
of America, Mobsy; 2002:730.
96. de Swiet M. Medical Disorders in Obstetric Practice.
Oxford, Blackwell Science Ltd; 1995: 607.
97. James F., Joann G., and David L. Epidemiology, biostatistics,
and preventive medicine. United State Of America, Saunders;1996:
104-106.
98. David E., and Stolley P.D. Foundation of epidemiology.
Third edition. New York, Oxford University Press; 1994:
172.
99. Dawson B., and Robert G. Basic and clinical biostatistics.
Fourth edition. A lange medical book. MCGraw-Hill Companies;
2004: 297.
100. Cassens B.J. Preventive medicine and public health.
Second edition. United State of America, Library of Congress;
1992:35.
101. Naylor C.D. Two cheers for meta analysis: Problem
and apportunities in aggregating results of clinical trials.
Canadian Medical Journal. 1988; 138: 891.
102. Lipsey M.W., Wilson D.B. Practical meta analysis
applied social research methods series. Thousand Oaks,
CA. Sage publication. 2001; Vol.49.
103. Jenicek M. Foundations of evidence based medicine.
London, The Parthenon publishing group; 2003: 303-320.
104. Zautra A., and Hempel A. Subjective wellbeing and
physical health: A narrative literature review with suggestions
for future research. International Journal of Aging Human
Development. 1984; 19:96.
105. Cook D.J., Mulrow C.D., and Haynes R.B. Systematic
reviews: Synthesis of best evidence for clinical decisions.
Annal Internal Medicine. 1977; 126: 377.
106. Light R.J., and Smith P.V. A ccumulating evidence:
Procedures for resolving contradictions among different
research studies. Harvard Educational Review. 1971; 41:
459.
107. Hedges L.V., and Olkin I. Vote counting methods
in research synthesis. Psychological Bull. 1980; 88: 365.
108. George L.K., Landerman R. Health and subjective
wellbeing: A replicated secondary data analysis. International
Journal of Aging Human Development. 1984; 19: 136.
109. Kassirer J.P. Clinical trials and meta analysis:
What do they do for us?. New England Journal of Medicine.
1992; 327: 274.
110.Dickersin K., and Berline J.A. Meta analysis: State
of the science. Epidemiological Review. 1992; 14:160.
111. Lau J., Ioannidis J.P.A., and Schmid C.H. Quantitative
synthesis in systematic reviews. Annal Internal Medicine.
1997; 127: 820.
112. Mulrow C.D., Cook D.J., and Davidoff F. Systematic
reviews: Critical links in the great chain of evidence.
Annal Internal Medicine. 1997; 126: 390.
113. MCQuay H.J., and Moore R.A. Using numerical results
from systematic reviews in clinical practice. Annal Internal
Medicine. 1997; 126: 712.
114. Badgett R.C., O`Keefe M., and Henderson M.C. Using
systematic reviews in clinical education. Annal Internal
Medicine. 1997; 126: 886.
115. Introduction to meta analysis and systemic reviews.
Report, 2000.
116. Hampton J.R. The end of medical history?. Journal
Roy. Collection Physics London. 1998; 147: 717.
117. Goldman L., and Feinstein A.R. Anticoagulants and
myocardial infarction: The problems of pooling, drowning,
and floating. Annal Internal Medicine. 1989;90: 93.
118. Naylor C.D. Two cheers for meta analysis: Problems
and apportunities in aggr-egating results of clinical
trials. Canadian Medical Assistant Journal. 1988; 138:891.
119. Goodman S.N. Have you ever meta analysis you didn`t
like?. Annal International Medicine. 1991; 114: 891.
120. Gerberg Z., and Horwitz R.I. Resolving conflicting
clinical trials: Guidelines for meta analysis. Journal
of Clinical Epidemiology. 1988; 41: 503.
121. Katz D.L. Epidemiology, biostatistics, and preventive
medicine review. United State Of America, Saunders;1997:52.
22. Greenland S. Invited commentary: A critical look at
some popular meta analytic methods. American Journal of
Epidemiology. 1994; 140: 290.
123. Jenicek M. Meta analysis in medicine. Evaluation
and synthesis clinical and epidemiological information.
Paris, E. Dis. E.M. and Maloine; 1987.
124. Gallagher E.J. Systematic reviews: A logical methodological
extension of evidence based medicine. Academic Emergency
Medicine. 1999; 6: 1256.
125. King J.C. The risk of maternal nutritional depletion
and poor outcome increases in early or closely spaced
pregnancies. Journal of Nutrition. 2003 May; 133(5 suppl
2): 1735.
126. Mahony R., and O`Herlihy c. Thirty year trends in
a large Irish obstetrics cohort. Irish Medical Journal.
2003 March; 96(3): 86.
127. Wasunna A., and Mohammed K. Low birth weight babies
sociodemographic and obstetric characteristics of adolescent
mothers at Kenyatta National Hospital, Nairobi. East Africa
Medical Journal. 2002 October; 79(10): 543.
128. Kirchengast S., and Hartmann B. Advanced maternal
age is not only associated with newborn somatometrics
but also with the mode of delivery. Annal Human Biology.
2003 January-February; 30(1): 1.
129. Donoso E., and Villarroel L. Reproductive risk of
women over 40 years old. Review of Medicine and Child
health. 2003 January; 131(1): 55.
130. Olatunji A.O., and Sule-Odu A.O. Maternal Mortality
at Sagamu, Nigeria- a ten year review (1988-1997). Niger
Postgraduat Medical Journal. 2001 March; 8(1): 12.
131. Williams K.P., and Wilson S. The impact of parity
on incidence of HELLP syndrome and small for gestational
age infants in hypertensive pregnant women. Journal of
Obstetric/ Gynecology in Canada. 2002 June; 24(6): 485.
132. Perren S., Von-wyl A., Simoni H., Stadlmayr W., Burgin
D., and Von-Klitizing K. Parental psyhopathology, marital
quality, and the transition to parenthood. American Journal
Orthopsychiatry. 2003 January; 73(1): 55.
133.US Conferences of Mayors. Hanger and homlessness
up sharply in a major United States cities. New York,
Authors: 2001.
134. National Coalition for homlessness (NCH fact sheet
No.8). Retrievered on September 16, 2002 from http://nch.
Ari. Net/ domestic. html.
135. Senat M.V., Ancel P.Y., Bouvier-Colle M.H., and
Breart G. How does multiple pregnancy affect maternal
mortality and morbidity?. Clinical Obstetrics and gynecology.
1998; 41: 79.
136. Jacquemyn Y., Martens G., Ruyssinck G., Michiels
I., and Van-Overmeire B. A matched cohort comparison of
the outcome of twin versus singleton pregnancies in Flanders,
Belgium. Twin Res.2003 Feb; 6(1): 10.
137. Francois K., Johnson J.M., and Harris C. Is placenta
previa more common in multiple gestations? American Journal
of Obstetric/ Gynecology. 2003 May; 188(5): 1226.
138. Lynch A., McDuffie R., Stephens J., Murphy J., Farber
K., and Orleaus M. The contribution of assisted conception
chorionicity and other risk factors to very low birth
weight twin cohort. British Journal of Obstetric/Gynecology.
2003 April; 110(4): 405.
139. Misic Z., Krezo S., Mamic I., et al. Perinatal care
in Livno immediately after the war from 1995-1999. Godine.
Medicine Arh. 2003; 57(1):39.
140. Boulet S.L., Alexander G.R., Salihu H.M., and Pass
M. Macrosomic births in the United State: Determinants,
outcomes, and proposed grades of risk. American Journal
of Obstetric Gynecology. 2003 May; 188(5): 1372.
141. Kyomuhendo G.B. Low use of rural maternity services
in Uganda: Impact of women`s status, traditional beliefs
and limited resources. Reproductive Health Matters. 2003
May; 11(21): 16.
142. Safdar S., Inam S.N., Omair A., and Ahmed S.T. Maternal
health care in a rural area of Pakistan. Journal of Park.
Medicine.
143. Sogaard M., and Vested-Jakobsen A. Consanguinity
and congenital abnormalities. Ugeskr-Laeger. 2003 April
28; 165(18): 1851.
144. Saad F.A., and Jauniax E. Recurrent early pregnancy
loss and consanguinity. Reproductive Biomedical Online.
2002 September-October; 5(2): 167.
145. Al-Bustan S.A., El-Zawahri M.M., Al-Adsani A.M.,
et al. Epidemiological and genetic study of 121 cases
of oral clefts in Kuwait. Orthopaedic Craniofacacial Res.
2002 August; 5(3): 154.
146.Anonymous. Birth spacing: Three to five save lives.
Population Reproductive Life.2002 Summer;13: 1-2.
147. Agustin Conde-Agudelo et al. Birth spacing and of
adverse perinatal outcomes. Journal of American Medical
Association. 2006; 295(15): 1809.
148. Finer L.B., Henshaw S.H. Abortion incidence and
services in the United States in 2000. Perspective Sexual
and Reproductive Health. 2003 January-February; 35(1):6.
149. Talukder S.I., and Haque A. Frequency of abortion
in different seasons and age group. Mymensingh Medical
Journal. 2003 January; 12(1): 8.
150. Qublan H.S., Jumaian N., Au Salem A., Hamadelol
F.Y., Mashagbeh M., and Abdel Ghani F. Journal of Obstetric/
Gynecology. 2002 May; 22(3): 296.
151. Diejomaoh M.F., Al-Azemi M., Jirous J., et al. The
aetiology and pattern of recurrent pregnancy loss. Journal
Obstetric/ Gynecology. 2002 January; 22(1): 58.
152. Chang J., Elam-Evans L.D., Berg C.J., et al. Pregnancy
related mortality surveillance United States 1991-1999.
MMWR. Surveillance Summary. 2003 February 21; 52(2): 1
153. Harvey S., Rach D., Stainton M.C., Jarrell J., and
Brant R. Evaluation of satisfaction with midwifery care.
Midwifery. 2002 December; 18(4): 260.
154. Nasheit N.A. Perinatal and neonatal mortality and
morbidity in Iraq. Journal of Maternal, Fetal and Neonatal
Medicine.2003 January; 13(1):64.
155. Neggers Y., and Goldenberg R.L. Some thoughts on
body mass index, micronutrient intake and pregnancy outcome.
Journal of Nutrition. 2003 May; 133(5 suppl 2): 1737s.
156. Garland S.M., Ni-Chuileannain F., Satzke C., and
Robins-Browne R. Mechanisms organisms and markers of infection
in pregnancy. Journal of Reproductive Immunology. 2002
October-November; 57(1-2): 169.
157. Ananth C.V., Smulian J.C., and Vintzileos A.M. The
effect of placenta previa on neonatal mortality: A population
based study in the United States 1989-1997. American Journal
of Obstetric/ Gynecology. 2003 May; 188(5): 1299.
158. Treger M., Hallak M., Silberstein T., Friger M.,
Katz M., and Mazor M. Post term pregnancy: Should induction
of labor be considered before 42 weeks?. Journal of Maternal,
Fetal and Neonatal Medicine. 2002 January; 11(1): 50.
159. Maghoma J., and Buchmann E.J. Maternal and fetal
risks associated with prolonged latent phase of labor.
Journal of Obstetric / Gynaecology. 2002 January; 22(1):
16.
160. Kaufman J., and Jing F. Privatisation of health
services and the reproductive health of rural Chinese
women. Reproductive Health Matters. 2002 November; 10(20):
108.
161. Janssen P.A., Lee S.K., Ryan E.R., and Saxell L.
An evaluation of process and protocols for planned home
birth attended by regulated midwives in British Columbia.
Journal of Midwifery Women Health. 2003 March-April; 48(2):
138.
162. Goldman N., and Glei D.A. Evaluation of midwifery
care: Results from a survey in rural Guatemala. Social
Scientific Medicine. 2003 February; 56(4): 685.
163. Sanchez-Ramos L., and Hsieh E. Pharmacologic methods
for cervical ripenin and labor induction. Current Women.
Health Report. 2003 February ; 3(1): 55.
164. Ben-Aissia N., Gara M.F., Yazidi M., Battar S.,
and Sadfi A. Delivery by forceps: Indications and maternofetal
morbidity. Tunis Medicine. 2003 March; 81(3): 180.
165. Shihadeh A., and Al-Najdawi W. Forceps or vacuum
extraction: A comparison of maternal and neonatal morbidity.
East Mediterranean Health Journal. 2001 January-March;
7(1-2): 106.
166. Bergholt T., Stenderup J.K., Vedsted-Jakobsen A.,
Helm P., and Lenstrup C. Intraoperative surgical complication
during C/S: An observational study of the incidence and
risk factors. Acta. Obstetric/ Gynecology in Scand. 2003
March; 82(3): 251.
167. Freeman R.K. Problems with intrapartum fetal heart
rate monitoring interpretation and patient management.
Obstetric/ Gynecology. 2002 October; 100(4): 813.
168. Williams K.P., and Galerneau F. Intrapartum fetal
heart rate patterns in the prediction of neonatal academia.
American Journal of Obstetric/ Gynecology. 2003 March;
188(3): 820.
169. Carbonne B., Gougeul V., and Fekih K.M. Intrapartum
fetal monitoring. Journal of Gynecology/ Obstetric and
Biological Reproduction.(Paris). 2003 February; 32: 1579.
170. Pattinson R.C., Howarth G.R., Macdonald A.P., Makin
J.D., and Funk M. Aggressive or expectant management of
labour: A randomized clinical trial. British Journal of
Obstetric/Gynecology. 2003 May; 110(5): 457.
171. Weiner C.P. Fetal hemolytic disease. In: James D.K.,
Steer P.J., Weiner C.P., and Gonik. High risk pregnancy
management options. 2nd edition. Philadelphia, Saunders
W.B.; 1999.
172. American College of Obstetricians and gynecologists
(ACOG). Prevention of RhD alloimmunization (ACOG Practice
Bulletin No.4). Washington DC, Author; 1999c.
173. Chakraborty N., Islam M.A., Chowdhury R.I., and Bari
W. Analysis of antepartum maternal morbidity in rural
Bangladesh. Australian Journal of Rural Health. 2003 January;
11(1): 22.
174. Buchmann E.J., Pattinson R.C., and Nyathikazi N.
Intrapartum related birth asphyxia in South Africa lessons
from the first national perinatal care survey. South Africa
Medical Journal. 2002 November; 92(11):897.
175. French M.R., Barr S.I., and Levy Milne R. Folate
intake and awareness of folate to prevent neural tube
defect: A survey of women living in Vancouver, Canada.
Journal of American Diet Association. 2003 February; 103(2):
181.
176. Barash J.H., and Weinstein L.C. Preconception and
prenatal care. Primary Care. 2002 September; 29(3): 519.
177. Correa A., Botto L., Liu Y., Mulinare J. and Erickson
J.D. Do Multivitamin supplements attenuate the risk for
diabetes associated birth defects? Paediatrics. 2003 May;
111(5 part 2): 1146.
178. Duley L., and Henderson-Smart D.J. Drugs for treatment
of very high blood pressure during pregnancy. Cochrane
Database Systemic Review. 2002; 4: CD 001449
179. Crane J, Armson A., Brunner M., et al. Antenatal
corticosteroid therapy for fetal maturation. Journal of
Obstetric/ Gynecology in Canada. 2003 January; 25(1):
45
180. Foong S.C., and Pollard J.K. Eclampsia in Southern
Alberta: Is there a role for seizure prophylaxis in all
women with gestational hypertension? Journal of Obstetric/
Gynecology in Canada 2003 May; 25(5): 385.
181. Malhorta M., Sharma J.B., Barta S., Sharma S., Murthy
N.S., and Arora R. Maternal and perinatal outcome in varying
degrees of anemia. International Journal of Gynaecology/
Obstetrics. 2002 November; 79(2): 93.
182. Beye M.D., Diouf E., Kane O., et al. Intensive care
managements of 28 patient with sever eclampsia in a tropical
African setting. Annal French Anesthesia Reanim. 2003
January; 22(1): 25.
183. Steel J.M., Johnstone F.D., Hepburn D.A., and Smith
S.A.F. Can pre pregnancy care of diabetic women reduce
the risk of abnormal babies?. British Medical Journal
1990; 301: 1070.
184. Aisien A.O., Lawson J.O., and Adebayo A.A. A five
year appraisal of cesarean section in Northern Nigeria
University Teaching Hospital. Niger Postgraduate Medical
Journal. 2002 September; 9(3): 146.
185. Kinzler W.L., Ananth C.V., Smulian J.C., and Vintzileos
A.M. The effects of labor on infant mortality among small
for gestational age infants in the United State of. America.
Journal of Maternal, Fetal and Neonatal Medicine.2002
September; 12(3): 201.
186. Bari W., Chowdhury R.I., Chakraborty N., and Akhter
H.A. The differentials and determinants of perinatal mortality
in rural Banghladesh. European Journal of Contraception
and Reproductive Health Care. 2002 December; 7(4): 216.
187. Sheiner E., Shoham-Vardi I., Hallak M.,et al. Placental
abruption in term pregnancies clinical significance and
obstetric risk factors. Journal of Maternal, Fetal and
Neonatal Medicine. 2003 January; 13(1):45.
188. Berg C.J, Chang J., Callaghan W.M., and Whitehead
S.J. Pregnancy related mortality in the United States
1991-1997. Obstetric/ Gynaecology. 2003 February; 101(2):
289.
189.Gaym A. A review of maternal mortality at Jimma Hospital,
Southwestern Ethiopia. Ethiopian Journal of Health Development.
2000; 14(2): 215-223.
190. Sloan N.L., Langer A., Hernandez B., Romero M.,
and Winikoff B. The etiology of maternal mortality in
developing countries: What do verbal autopsies tell us?
Bulletin of the World Health Organization. 2001; 79: 805-810.
 |
| Appendix
I |
|
Name:
Age: Number:
Occupation:
Residence: Urban / Rural
Marital state: Married / Divorce
/ Widow / Separated
Educational level:
Illiterate / Primary education / Secondary education
/ Higher education
Socio economic level: Low
/ Middle / High
Blood group and Rh:
Husband age:
Husband occupation:
Husband blood group and Rh:
Are they relative? Yes
/ No
Degree of relation: First
degree / Second degree
**Antenatal care:
Gravida / Para / Abortion /
LMP / EDD
No. of current pregnancy:
If pregnancy: Single / Multiple
Method of pregnancy diagnosis:
Urine / U/S / Non
Gestational
age:
Trimester:
1st / 2nd / 3rd
Site
of ANC: Private / PHCC / Both
Time
of 1st visit:
Frequency
of visit:
Type
of ANC: Adequate / Not adequate
Immunization:
High
risk group: Yes / No
Cause
of risk:
Any
investigation done during pregnancy:
Radiation
exposure: Yes / No
Time
of it:
Drugs
taken during pregnancy:
Any
complication:
**Abortion
& still birth:
Gestational
age:
Trimester:
1st / 2nd / 3rd
Type
of abortion:
Cause of it:
Any complication:
**Natal care:
Date of delivery:
Labour: Full term pregnancy
/ Preterm / Post term
Site of delivery: Hospital
/ Home
If home delivery by:
Registered midwife / Not registered
midwife / Not aided at all
Duration of labour:
Type of delivery: NVD / C/S
/ NVD with induction / Instrumental
If C/S: Elective / Emergency
Why C/S?
Complication of C/S:
Complication of NVD:
Type of fetal monitoring during
labour:
FH each 1/2h / Partogram
/ PH estimation
Sex of baby: Male / Female
Weight of baby:
If baby: Normal / Abnormal
Abnormal due to congenital
anomalies: Yes / No
What’s the anomaly? :
Abnormality due to complication
of labour:
RDS / Fracture / Cerebral
palsy / Intracranial haemorrhage
**PNC:
1st visit time post termination:
Immunization:
Prolonged lochia: Yes / No
Complication: Early / Late
Early: PPH / Sudden post
partum collapse
PPH: Primary / Secondary
Primary PPH: Uterine inertia
/ Genital tract injury
Secondary PPH: Infection /
Retained placental piece
Sudden post partum collapse:
Internal bleeding / Embolism / Eclamptic fit
Late complication: Mastitis
/ UTI / Wound infection / Purperial sepsis
##Past obstetrical history:
No. of previous pregnancies:
History of multiple pregnancy:
Mode of delivery: NVD / C/S
/ No. of C/S
ANC & PNC in previous pregnancies:
Adequate / Not adequate
Complications of previous pregnancies:
Outcome (fetus): Normal / Abnormal
/ Death
Any admission to neonatal care
unit: Yes / No
Purperium of previous labour:
Spacing: >2 years / <2years
Contraception use: Yes / No
Type of contraception: Natural
/ Hormonal / IUCD / Barrier
History of infertility: Yes
/ No
Infertility: Primary / Secondary
##Menstrual history:
Menarche:
Frequency:
Dysmenorrhea: Yes / No
##Drug history:
1-Preconceptional preventive
drugs: Folic acid / Aspirin
2-Specific diseases: Hypertension
/ DM / Others
3-Regarding pregnancy: Tonics
/ Others
##Medical history:
##Surgical history:
##Social history: Smoking
/ Alcoholic / Drug addiction
##Family history:
|
|
Appendix II - High Risk Evaluation
Form(15)
|
|
*Reproductive
history
|
|
Age: <16 years
16-35
>35
|
4.0>1 |
| 4.0>0 |
| 4.0>2
|
|
Parity:t;5
|
4.0>1 |
| 4.0>0
|
| 4.0>2 |
|
Two or more abortion or history of infertility
|
4.0>1 |
|
Postpartum bleeding or manual removal of placenta.
|
4.0>1 |
| 4.0>2 |
| Column Total
|
|
*Medical
or surgical associated condition
|
|
Previous gynecological surgery.
|
4.0>1
|
|
Chronic renal diseases`
|
4.0>1 |
|
Gestational diabetes A.
|
4.0>1 |
|
Class B or greater diabetes.
|
4.0>3 |
|
Cardiac diseases.
|
4.0>3 |
|
Other significant medical disorder (1-3) according
to severity.
|
4.0>1-3 |
| Column Total |
|
|
*Present
pregnancy
|
|
Bleeding: <20 week
>20 week
|
4.0>1 |
| 4.0>3 |
|
Anemia (<10 g/l)
|
4.0>1 |
|
Postmaturity.
|
4.0>1 |
|
Hypertension.
|
4.0>2 |
|
PROM.
|
4.0>2 |
|
Polyhydramnios.
|
4.0>2 |
|
I.U.G.R.
|
4.0>3 |
|
Multiple pregnancy.
|
4.0>3 |
|
Breech or malpresentation.
|
4.0>3 |
|
Rh-isoimmunization.
|
4.0>3 |
| Column Total |
|
*Total Score
(summation of 3 columns).
-Low risk
0-2
-High risk
3-6
-Sever risk
7 or more
|
 |